| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Alzheimer Disease | 528 | 2024 | 905 | 48.540 |
Why?
|
| Oxidative Stress | 200 | 2020 | 938 | 14.980 |
Why?
|
| Brain | 191 | 2024 | 1346 | 11.960 |
Why?
|
| tau Proteins | 106 | 2024 | 167 | 9.460 |
Why?
|
| Neurodegenerative Diseases | 47 | 2024 | 131 | 6.930 |
Why?
|
| Neurons | 151 | 2021 | 1175 | 6.740 |
Why?
|
| Mitochondria | 71 | 2023 | 487 | 6.300 |
Why?
|
| Neurofibrillary Tangles | 85 | 2022 | 113 | 5.690 |
Why?
|
| Humans | 697 | 2024 | 37093 | 5.670 |
Why?
|
| Aging | 53 | 2021 | 664 | 4.980 |
Why?
|
| Animals | 323 | 2024 | 15081 | 3.990 |
Why?
|
| Dementia | 17 | 2024 | 131 | 3.860 |
Why?
|
| Parkinson Disease | 36 | 2019 | 178 | 3.620 |
Why?
|
| Oxidation-Reduction | 66 | 2020 | 431 | 3.450 |
Why?
|
| Antioxidants | 43 | 2020 | 416 | 3.400 |
Why?
|
| Iron | 42 | 2024 | 225 | 3.370 |
Why?
|
| Hippocampus | 79 | 2024 | 561 | 3.360 |
Why?
|
| Amyloid | 27 | 2023 | 54 | 3.220 |
Why?
|
| Amyloid beta-Protein Precursor | 48 | 2019 | 95 | 3.100 |
Why?
|
| Peptide Fragments | 34 | 2018 | 308 | 2.820 |
Why?
|
| Immunohistochemistry | 112 | 2021 | 893 | 2.510 |
Why?
|
| Aged | 186 | 2024 | 6741 | 2.430 |
Why?
|
| Nervous System Diseases | 9 | 2022 | 71 | 2.350 |
Why?
|
| Evolution, Molecular | 14 | 2021 | 268 | 2.350 |
Why?
|
| RNA | 15 | 2017 | 241 | 2.240 |
Why?
|
| Neuroprotective Agents | 20 | 2020 | 245 | 2.190 |
Why?
|
| Aldehydes | 26 | 2013 | 69 | 2.140 |
Why?
|
| Aged, 80 and over | 123 | 2020 | 2379 | 2.130 |
Why?
|
| Reactive Oxygen Species | 39 | 2020 | 461 | 2.040 |
Why?
|
| Selection, Genetic | 5 | 2021 | 54 | 2.030 |
Why?
|
| Nerve Degeneration | 25 | 2018 | 107 | 2.000 |
Why?
|
| Genome, Human | 10 | 2021 | 135 | 1.990 |
Why?
|
| Metals | 18 | 2020 | 98 | 1.860 |
Why?
|
| Genome | 6 | 2021 | 125 | 1.830 |
Why?
|
| Tauopathies | 7 | 2022 | 20 | 1.810 |
Why?
|
| Neurofilament Proteins | 15 | 2013 | 29 | 1.770 |
Why?
|
| Disease Models, Animal | 45 | 2024 | 1371 | 1.690 |
Why?
|
| Lipid Peroxidation | 22 | 2013 | 140 | 1.690 |
Why?
|
| Protein Processing, Post-Translational | 12 | 2018 | 173 | 1.640 |
Why?
|
| Genetic Variation | 14 | 2022 | 387 | 1.640 |
Why?
|
| Cerebral Cortex | 39 | 2023 | 290 | 1.590 |
Why?
|
| Guanosine | 17 | 2017 | 27 | 1.590 |
Why?
|
| DNA, Mitochondrial | 17 | 2022 | 175 | 1.590 |
Why?
|
| Mice, Transgenic | 43 | 2024 | 617 | 1.550 |
Why?
|
| Mice | 98 | 2024 | 5913 | 1.490 |
Why?
|
| Pan troglodytes | 6 | 2010 | 21 | 1.490 |
Why?
|
| Proteins | 12 | 2020 | 369 | 1.470 |
Why?
|
| Thermodynamics | 5 | 2018 | 216 | 1.430 |
Why?
|
| Biomedical Research | 8 | 2022 | 400 | 1.430 |
Why?
|
| Free Radicals | 24 | 2010 | 74 | 1.410 |
Why?
|
| Copper | 20 | 2018 | 105 | 1.370 |
Why?
|
| Encephalitis | 6 | 2023 | 42 | 1.360 |
Why?
|
| Up-Regulation | 16 | 2020 | 513 | 1.360 |
Why?
|
| Autophagy | 10 | 2017 | 116 | 1.300 |
Why?
|
| Clinical Trials as Topic | 11 | 2023 | 204 | 1.280 |
Why?
|
| Nerve Tissue Proteins | 28 | 2015 | 360 | 1.260 |
Why?
|
| Gene Dosage | 8 | 2008 | 75 | 1.240 |
Why?
|
| Nanoparticles | 8 | 2019 | 318 | 1.230 |
Why?
|
| Lemur | 2 | 2021 | 4 | 1.210 |
Why?
|
| Hormones | 6 | 2018 | 55 | 1.200 |
Why?
|
| Middle Aged | 121 | 2020 | 10129 | 1.190 |
Why?
|
| Phenotype | 11 | 2022 | 689 | 1.190 |
Why?
|
| Nanotechnology | 3 | 2018 | 153 | 1.190 |
Why?
|
| Cell Nucleus | 11 | 2021 | 366 | 1.130 |
Why?
|
| Apolipoproteins E | 13 | 2020 | 129 | 1.130 |
Why?
|
| Body Height | 2 | 2022 | 53 | 1.130 |
Why?
|
| Editorial Policies | 3 | 2018 | 13 | 1.130 |
Why?
|
| Phosphorylation | 47 | 2024 | 928 | 1.120 |
Why?
|
| Nucleic Acids | 4 | 2017 | 24 | 1.100 |
Why?
|
| alpha-Synuclein | 12 | 2023 | 52 | 1.090 |
Why?
|
| Telomere | 2 | 2016 | 56 | 1.040 |
Why?
|
| Cerebrovascular Disorders | 9 | 2008 | 37 | 1.040 |
Why?
|
| Neurites | 11 | 2017 | 39 | 1.010 |
Why?
|
| Genetics, Population | 4 | 2021 | 100 | 1.000 |
Why?
|
| Genomics | 8 | 2023 | 223 | 0.990 |
Why?
|
| Adaptation, Physiological | 6 | 2023 | 109 | 0.990 |
Why?
|
| Neurology | 2 | 2018 | 12 | 0.980 |
Why?
|
| Phylogeny | 6 | 2021 | 644 | 0.970 |
Why?
|
| Primates | 3 | 2011 | 36 | 0.960 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2024 | 59 | 0.950 |
Why?
|
| Cytoskeleton | 19 | 2002 | 110 | 0.940 |
Why?
|
| Cognition | 13 | 2023 | 398 | 0.930 |
Why?
|
| Male | 119 | 2024 | 20025 | 0.920 |
Why?
|
| Brain Chemistry | 23 | 2020 | 140 | 0.920 |
Why?
|
| Membrane Proteins | 28 | 2018 | 517 | 0.910 |
Why?
|
| Models, Neurological | 9 | 2018 | 128 | 0.910 |
Why?
|
| DNA | 11 | 2021 | 574 | 0.900 |
Why?
|
| Energy Metabolism | 7 | 2018 | 168 | 0.890 |
Why?
|
| Hyperinsulinism | 1 | 2022 | 17 | 0.880 |
Why?
|
| Neurofibrils | 16 | 2013 | 23 | 0.870 |
Why?
|
| Amyloidosis | 11 | 2023 | 33 | 0.860 |
Why?
|
| Entorhinal Cortex | 4 | 2020 | 13 | 0.860 |
Why?
|
| Agriculture | 2 | 2022 | 56 | 0.840 |
Why?
|
| RNA, Transfer | 3 | 2018 | 28 | 0.840 |
Why?
|
| Female | 113 | 2024 | 20969 | 0.840 |
Why?
|
| Skeleton | 1 | 2022 | 2 | 0.840 |
Why?
|
| Pyramidal Cells | 12 | 2018 | 63 | 0.830 |
Why?
|
| Mitochondrial Proteins | 14 | 2018 | 107 | 0.830 |
Why?
|
| Multifactorial Inheritance | 2 | 2019 | 19 | 0.830 |
Why?
|
| Protein Biosynthesis | 4 | 2018 | 133 | 0.820 |
Why?
|
| Health | 1 | 2022 | 30 | 0.820 |
Why?
|
| Vaccines | 1 | 2023 | 55 | 0.810 |
Why?
|
| Microscopy, Electron | 32 | 2021 | 209 | 0.810 |
Why?
|
| Immunoblotting | 37 | 2010 | 176 | 0.810 |
Why?
|
| Diabetic Retinopathy | 1 | 2022 | 68 | 0.800 |
Why?
|
| Prediabetic State | 1 | 2022 | 53 | 0.800 |
Why?
|
| Extinction, Biological | 1 | 2021 | 2 | 0.800 |
Why?
|
| DNA Damage | 12 | 2021 | 352 | 0.790 |
Why?
|
| Somatotypes | 1 | 2021 | 4 | 0.790 |
Why?
|
| Publishing | 2 | 2020 | 24 | 0.790 |
Why?
|
| Heme Oxygenase (Decyclizing) | 17 | 2004 | 30 | 0.790 |
Why?
|
| Thioctic Acid | 4 | 2009 | 14 | 0.790 |
Why?
|
| Anthropology, Physical | 1 | 2021 | 9 | 0.780 |
Why?
|
| Genome, Mitochondrial | 1 | 2021 | 12 | 0.780 |
Why?
|
| Body Size | 1 | 2021 | 32 | 0.780 |
Why?
|
| Down-Regulation | 4 | 2020 | 435 | 0.770 |
Why?
|
| Gastropoda | 1 | 2021 | 11 | 0.770 |
Why?
|
| MAP Kinase Signaling System | 6 | 2017 | 169 | 0.760 |
Why?
|
| Iron Chelating Agents | 6 | 2012 | 21 | 0.760 |
Why?
|
| Cerebrovascular Circulation | 11 | 2015 | 70 | 0.760 |
Why?
|
| Neurotransmitter Agents | 3 | 2020 | 63 | 0.760 |
Why?
|
| Lewy Body Disease | 7 | 2023 | 14 | 0.760 |
Why?
|
| Leptin | 4 | 2015 | 118 | 0.750 |
Why?
|
| Writing | 1 | 2020 | 37 | 0.750 |
Why?
|
| Microtubule-Associated Proteins | 19 | 2018 | 85 | 0.730 |
Why?
|
| Glucose | 5 | 2018 | 230 | 0.730 |
Why?
|
| Tubulin | 5 | 2018 | 88 | 0.730 |
Why?
|
| Lipids | 5 | 2020 | 235 | 0.730 |
Why?
|
| Immunologic Factors | 1 | 2020 | 45 | 0.720 |
Why?
|
| Intermediate Filaments | 14 | 1991 | 19 | 0.720 |
Why?
|
| Dementia, Vascular | 4 | 2012 | 36 | 0.720 |
Why?
|
| Case-Control Studies | 24 | 2017 | 1130 | 0.710 |
Why?
|
| Alzheimer Vaccines | 4 | 2006 | 4 | 0.710 |
Why?
|
| Biological Products | 2 | 2022 | 71 | 0.710 |
Why?
|
| Erythrocytes | 8 | 2013 | 111 | 0.700 |
Why?
|
| Plant Extracts | 3 | 2021 | 286 | 0.700 |
Why?
|
| Axonal Transport | 5 | 2018 | 10 | 0.700 |
Why?
|
| Stroke | 3 | 2023 | 286 | 0.700 |
Why?
|
| Apolipoprotein E4 | 7 | 2018 | 47 | 0.700 |
Why?
|
| Inclusion Bodies | 12 | 2010 | 33 | 0.690 |
Why?
|
| Base Sequence | 14 | 2021 | 997 | 0.690 |
Why?
|
| Brain Injuries | 3 | 2019 | 121 | 0.690 |
Why?
|
| Chelation Therapy | 4 | 2012 | 4 | 0.690 |
Why?
|
| Signal Transduction | 27 | 2019 | 1908 | 0.680 |
Why?
|
| Cerebral Arteries | 9 | 2007 | 24 | 0.680 |
Why?
|
| Anti-Inflammatory Agents | 2 | 2020 | 149 | 0.670 |
Why?
|
| Aquaporin 3 | 1 | 2019 | 3 | 0.670 |
Why?
|
| Models, Biological | 23 | 2016 | 677 | 0.670 |
Why?
|
| Erythrocyte Membrane | 1 | 2019 | 20 | 0.670 |
Why?
|
| Amyloid Precursor Protein Secretases | 12 | 2015 | 33 | 0.670 |
Why?
|
| Drug Design | 4 | 2023 | 162 | 0.670 |
Why?
|
| Glycerol | 1 | 2019 | 28 | 0.660 |
Why?
|
| Axons | 9 | 2016 | 108 | 0.660 |
Why?
|
| Diabetes Mellitus, Type 2 | 5 | 2023 | 643 | 0.660 |
Why?
|
| Endothelium, Vascular | 14 | 2004 | 237 | 0.650 |
Why?
|
| Neuroblastoma | 22 | 2019 | 129 | 0.650 |
Why?
|
| Gait | 1 | 2019 | 25 | 0.650 |
Why?
|
| Endothelin-1 | 4 | 2015 | 55 | 0.650 |
Why?
|
| Cattle | 4 | 2020 | 477 | 0.650 |
Why?
|
| Glucose Transporter Type 3 | 1 | 2018 | 3 | 0.650 |
Why?
|
| Gene Expression Regulation | 20 | 2018 | 1015 | 0.650 |
Why?
|
| Lysine | 11 | 2013 | 113 | 0.640 |
Why?
|
| Bacteria | 2 | 2020 | 255 | 0.640 |
Why?
|
| Sex Factors | 3 | 2021 | 898 | 0.640 |
Why?
|
| Transfer RNA Aminoacylation | 1 | 2018 | 1 | 0.640 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 68 | 0.630 |
Why?
|
| Histocytochemistry | 11 | 2012 | 50 | 0.630 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 76 | 0.630 |
Why?
|
| Xylose | 1 | 2017 | 11 | 0.610 |
Why?
|
| Rats | 49 | 2022 | 3483 | 0.610 |
Why?
|
| MicroRNAs | 2 | 2020 | 426 | 0.610 |
Why?
|
| Symporters | 1 | 2017 | 11 | 0.610 |
Why?
|
| Cognition Disorders | 9 | 2018 | 233 | 0.610 |
Why?
|
| Olfactory Bulb | 1 | 2018 | 48 | 0.600 |
Why?
|
| Gastrointestinal Tract | 1 | 2018 | 61 | 0.600 |
Why?
|
| Molecular Dynamics Simulation | 7 | 2018 | 133 | 0.600 |
Why?
|
| Aspartic Acid Endopeptidases | 10 | 2012 | 19 | 0.600 |
Why?
|
| Lipid Bilayers | 1 | 2018 | 68 | 0.600 |
Why?
|
| GTP Phosphohydrolases | 7 | 2018 | 30 | 0.590 |
Why?
|
| Body Fluids | 1 | 2017 | 17 | 0.590 |
Why?
|
| Sequence Analysis, DNA | 7 | 2021 | 474 | 0.590 |
Why?
|
| Boxing | 1 | 2017 | 1 | 0.590 |
Why?
|
| Sodium Chloride | 1 | 2017 | 55 | 0.590 |
Why?
|
| Prions | 7 | 2012 | 25 | 0.580 |
Why?
|
| Heart | 1 | 2018 | 180 | 0.580 |
Why?
|
| History, 21st Century | 8 | 2015 | 81 | 0.580 |
Why?
|
| Marine Biology | 1 | 2016 | 7 | 0.580 |
Why?
|
| Ferrosoferric Oxide | 2 | 2016 | 11 | 0.570 |
Why?
|
| Cation Transport Proteins | 2 | 2016 | 34 | 0.570 |
Why?
|
| Adult | 54 | 2022 | 11712 | 0.570 |
Why?
|
| History, 20th Century | 8 | 2015 | 117 | 0.570 |
Why?
|
| Amyotrophic Lateral Sclerosis | 9 | 2024 | 46 | 0.570 |
Why?
|
| Iron Overload | 1 | 2016 | 8 | 0.560 |
Why?
|
| Sciatic Nerve | 4 | 2013 | 11 | 0.560 |
Why?
|
| Zinc | 8 | 2018 | 128 | 0.560 |
Why?
|
| Cytokines | 5 | 2018 | 602 | 0.560 |
Why?
|
| Research | 2 | 2013 | 163 | 0.550 |
Why?
|
| Escherichia coli Proteins | 1 | 2017 | 126 | 0.550 |
Why?
|
| Disease Progression | 19 | 2019 | 601 | 0.550 |
Why?
|
| Apoptosis | 18 | 2012 | 1398 | 0.550 |
Why?
|
| Genetics, Medical | 1 | 2016 | 6 | 0.550 |
Why?
|
| Cell Death | 17 | 2018 | 267 | 0.540 |
Why?
|
| Nutritional Status | 1 | 2017 | 116 | 0.540 |
Why?
|
| Temporal Lobe | 11 | 2003 | 21 | 0.540 |
Why?
|
| Prion Diseases | 6 | 2010 | 9 | 0.540 |
Why?
|
| Protein Binding | 15 | 2020 | 972 | 0.530 |
Why?
|
| Opioid-Related Disorders | 1 | 2018 | 125 | 0.530 |
Why?
|
| Cell Cycle | 11 | 2019 | 326 | 0.520 |
Why?
|
| Polymorphism, Single Nucleotide | 8 | 2023 | 767 | 0.520 |
Why?
|
| Astrocytes | 15 | 2012 | 255 | 0.520 |
Why?
|
| Synapses | 8 | 2023 | 180 | 0.510 |
Why?
|
| Phytotherapy | 1 | 2015 | 81 | 0.510 |
Why?
|
| Antibodies | 15 | 2013 | 141 | 0.510 |
Why?
|
| Journalism, Medical | 1 | 2015 | 5 | 0.510 |
Why?
|
| Fibroblast Growth Factor 2 | 7 | 2002 | 43 | 0.510 |
Why?
|
| Luteinizing Hormone | 11 | 2015 | 63 | 0.510 |
Why?
|
| Microtubules | 9 | 2010 | 120 | 0.500 |
Why?
|
| Chemistry, Pharmaceutical | 2 | 2012 | 71 | 0.500 |
Why?
|
| Particulate Matter | 1 | 2015 | 51 | 0.500 |
Why?
|
| Indoles | 5 | 2021 | 158 | 0.500 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 4 | 2020 | 103 | 0.500 |
Why?
|
| Pregnancy Rate | 2 | 2020 | 13 | 0.500 |
Why?
|
| Antibodies, Monoclonal | 19 | 2023 | 290 | 0.500 |
Why?
|
| Neoplasms | 3 | 2023 | 1103 | 0.490 |
Why?
|
| Mitogen-Activated Protein Kinases | 14 | 2008 | 136 | 0.490 |
Why?
|
| Ceruloplasmin | 5 | 2013 | 15 | 0.490 |
Why?
|
| Pathology | 2 | 2011 | 7 | 0.480 |
Why?
|
| Plasmodium falciparum | 4 | 2016 | 135 | 0.480 |
Why?
|
| Binding Sites | 10 | 2018 | 651 | 0.480 |
Why?
|
| Supranuclear Palsy, Progressive | 10 | 2021 | 12 | 0.480 |
Why?
|
| DNA Repair | 3 | 2012 | 188 | 0.470 |
Why?
|
| Gene Deletion | 2 | 2007 | 166 | 0.470 |
Why?
|
| Vitamin D Deficiency | 1 | 2015 | 105 | 0.470 |
Why?
|
| Olfactory Mucosa | 2 | 2004 | 18 | 0.460 |
Why?
|
| Informed Consent | 1 | 2014 | 31 | 0.460 |
Why?
|
| Tyrosine | 10 | 2004 | 118 | 0.460 |
Why?
|
| Cells, Cultured | 29 | 2018 | 1518 | 0.460 |
Why?
|
| Child | 21 | 2022 | 3131 | 0.460 |
Why?
|
| Serum Amyloid P-Component | 5 | 2002 | 20 | 0.460 |
Why?
|
| Neuroglia | 8 | 2021 | 124 | 0.460 |
Why?
|
| Chronic Disease | 2 | 2017 | 484 | 0.460 |
Why?
|
| Oxygen | 8 | 2008 | 207 | 0.450 |
Why?
|
| Pregnancy, Animal | 1 | 2013 | 16 | 0.450 |
Why?
|
| Molecular Sequence Data | 17 | 2013 | 1568 | 0.450 |
Why?
|
| Drug Delivery Systems | 4 | 2019 | 202 | 0.440 |
Why?
|
| RNA, Messenger | 17 | 2018 | 1207 | 0.440 |
Why?
|
| Depressive Disorder, Major | 1 | 2014 | 103 | 0.440 |
Why?
|
| Heme Oxygenase-1 | 15 | 2010 | 51 | 0.440 |
Why?
|
| Muscle, Skeletal | 4 | 2018 | 282 | 0.430 |
Why?
|
| Technology, Pharmaceutical | 2 | 2012 | 27 | 0.430 |
Why?
|
| Diet | 8 | 2023 | 801 | 0.430 |
Why?
|
| Huntington Disease | 8 | 2013 | 27 | 0.430 |
Why?
|
| Cytoplasm | 16 | 2009 | 143 | 0.430 |
Why?
|
| Microscopy, Immunoelectron | 15 | 2011 | 34 | 0.430 |
Why?
|
| Vaccination | 4 | 2013 | 288 | 0.430 |
Why?
|
| Genome-Wide Association Study | 3 | 2024 | 333 | 0.420 |
Why?
|
| Homeostasis | 12 | 2010 | 188 | 0.420 |
Why?
|
| Erythroblastosis, Fetal | 1 | 2012 | 1 | 0.420 |
Why?
|
| Rh-Hr Blood-Group System | 1 | 2012 | 4 | 0.420 |
Why?
|
| Microglia | 13 | 2021 | 166 | 0.420 |
Why?
|
| Lewy Bodies | 6 | 2017 | 30 | 0.420 |
Why?
|
| Nanomedicine | 1 | 2012 | 35 | 0.410 |
Why?
|
| Immunotherapy | 5 | 2023 | 95 | 0.410 |
Why?
|
| Darkness | 1 | 2011 | 27 | 0.410 |
Why?
|
| Aorta, Abdominal | 2 | 2003 | 9 | 0.410 |
Why?
|
| Drug Carriers | 2 | 2012 | 125 | 0.410 |
Why?
|
| Down Syndrome | 8 | 2014 | 29 | 0.400 |
Why?
|
| Metabolic Diseases | 3 | 2018 | 33 | 0.400 |
Why?
|
| Decision Making | 1 | 2014 | 203 | 0.400 |
Why?
|
| Transfection | 18 | 2018 | 523 | 0.400 |
Why?
|
| Sequence Analysis, RNA | 1 | 2011 | 106 | 0.390 |
Why?
|
| Species Specificity | 7 | 2011 | 245 | 0.390 |
Why?
|
| Gene Expression Profiling | 4 | 2024 | 626 | 0.380 |
Why?
|
| Oxidants | 3 | 2009 | 45 | 0.380 |
Why?
|
| Chemoprevention | 2 | 2017 | 35 | 0.380 |
Why?
|
| Carrier Proteins | 8 | 2010 | 305 | 0.380 |
Why?
|
| Rod Opsins | 2 | 2008 | 15 | 0.380 |
Why?
|
| Movement Disorders | 2 | 2019 | 8 | 0.370 |
Why?
|
| Disease Susceptibility | 3 | 2023 | 97 | 0.370 |
Why?
|
| Epitopes | 14 | 2005 | 148 | 0.370 |
Why?
|
| Contrast Media | 2 | 2018 | 92 | 0.370 |
Why?
|
| Adaptation, Biological | 2 | 2021 | 24 | 0.370 |
Why?
|
| Diagnostic Imaging | 1 | 2011 | 53 | 0.370 |
Why?
|
| Gene Expression | 11 | 2018 | 674 | 0.370 |
Why?
|
| DNA-Binding Proteins | 6 | 2024 | 539 | 0.360 |
Why?
|
| Estrogens | 9 | 2020 | 202 | 0.360 |
Why?
|
| Periodicals as Topic | 1 | 2011 | 49 | 0.360 |
Why?
|
| Risk Factors | 15 | 2018 | 3562 | 0.360 |
Why?
|
| Melatonin | 6 | 2015 | 82 | 0.360 |
Why?
|
| Blood-Brain Barrier | 11 | 2018 | 162 | 0.360 |
Why?
|
| Feces | 1 | 2010 | 111 | 0.360 |
Why?
|
| Nitric Oxide | 5 | 2007 | 316 | 0.360 |
Why?
|
| Adolescent | 25 | 2016 | 5363 | 0.360 |
Why?
|
| Pathology, Clinical | 1 | 2009 | 4 | 0.360 |
Why?
|
| Endopeptidases | 6 | 2006 | 59 | 0.360 |
Why?
|
| Protein Precursors | 8 | 1996 | 61 | 0.350 |
Why?
|
| Monosaccharide Transport Proteins | 6 | 1993 | 15 | 0.350 |
Why?
|
| Tropomyosin | 6 | 1993 | 15 | 0.350 |
Why?
|
| Models, Genetic | 3 | 2008 | 172 | 0.350 |
Why?
|
| Immunoenzyme Techniques | 20 | 2008 | 108 | 0.350 |
Why?
|
| Mice, Inbred C57BL | 17 | 2019 | 1609 | 0.350 |
Why?
|
| Awards and Prizes | 1 | 2009 | 29 | 0.340 |
Why?
|
| Ubiquitins | 12 | 1998 | 46 | 0.340 |
Why?
|
| Time Factors | 18 | 2018 | 1742 | 0.340 |
Why?
|
| Kinetics | 6 | 2017 | 708 | 0.340 |
Why?
|
| Chelating Agents | 6 | 2012 | 57 | 0.340 |
Why?
|
| Gonadotropins | 8 | 2008 | 27 | 0.330 |
Why?
|
| Fibroblasts | 4 | 2017 | 272 | 0.330 |
Why?
|
| Color Vision | 1 | 2008 | 7 | 0.330 |
Why?
|
| Hematopoietic Stem Cell Mobilization | 1 | 2008 | 2 | 0.330 |
Why?
|
| Superoxide Dismutase | 9 | 2013 | 155 | 0.330 |
Why?
|
| Parathyroid Hormone | 1 | 2008 | 37 | 0.320 |
Why?
|
| Muscular Atrophy | 2 | 2018 | 13 | 0.320 |
Why?
|
| Growth Hormone | 2 | 2018 | 31 | 0.320 |
Why?
|
| Enzyme Activation | 20 | 2016 | 444 | 0.320 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2008 | 41 | 0.320 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2008 | 43 | 0.320 |
Why?
|
| Tandem Repeat Sequences | 1 | 2008 | 9 | 0.320 |
Why?
|
| Protein Conformation | 7 | 2017 | 389 | 0.320 |
Why?
|
| Nootropic Agents | 3 | 2015 | 7 | 0.310 |
Why?
|
| Treatment Failure | 2 | 2012 | 64 | 0.310 |
Why?
|
| Ischemia | 1 | 2008 | 46 | 0.310 |
Why?
|
| Cell Line | 12 | 2018 | 1354 | 0.310 |
Why?
|
| Dietary Supplements | 6 | 2020 | 208 | 0.310 |
Why?
|
| Electron Transport Complex IV | 6 | 2011 | 37 | 0.310 |
Why?
|
| Mitochondrial Diseases | 4 | 2012 | 16 | 0.310 |
Why?
|
| Hydrogen Peroxide | 11 | 2013 | 190 | 0.310 |
Why?
|
| alpha-Amylases | 1 | 2007 | 6 | 0.310 |
Why?
|
| RNA, Ribosomal | 3 | 2011 | 25 | 0.310 |
Why?
|
| Systems Biology | 2 | 2021 | 22 | 0.300 |
Why?
|
| Chlamydia Infections | 2 | 2015 | 196 | 0.300 |
Why?
|
| Insulin | 4 | 2012 | 236 | 0.300 |
Why?
|
| Color Perception | 1 | 2007 | 17 | 0.300 |
Why?
|
| Nitric Oxide Synthase | 7 | 2006 | 128 | 0.300 |
Why?
|
| Cell Survival | 15 | 2015 | 864 | 0.300 |
Why?
|
| Neovascularization, Physiologic | 2 | 2008 | 73 | 0.300 |
Why?
|
| Endothelial Cells | 2 | 2008 | 308 | 0.290 |
Why?
|
| Microcirculation | 7 | 2008 | 37 | 0.290 |
Why?
|
| Chromosomes, Human, Y | 1 | 2007 | 15 | 0.290 |
Why?
|
| Deoxyguanosine | 3 | 2003 | 35 | 0.290 |
Why?
|
| Acetylcysteine | 1 | 2007 | 62 | 0.290 |
Why?
|
| Obesity | 1 | 2015 | 1067 | 0.290 |
Why?
|
| Gonadotropin-Releasing Hormone | 4 | 2020 | 33 | 0.290 |
Why?
|
| Sex Characteristics | 5 | 2014 | 230 | 0.290 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 5 | 2002 | 40 | 0.280 |
Why?
|
| Leuprolide | 4 | 2015 | 8 | 0.280 |
Why?
|
| Paraffin Embedding | 2 | 2020 | 12 | 0.280 |
Why?
|
| Brain Neoplasms | 4 | 2006 | 111 | 0.280 |
Why?
|
| Tryptamines | 2 | 2018 | 7 | 0.280 |
Why?
|
| Reference Values | 17 | 2004 | 212 | 0.280 |
Why?
|
| Diabetes Mellitus | 4 | 2012 | 485 | 0.280 |
Why?
|
| PrPC Proteins | 5 | 2011 | 5 | 0.280 |
Why?
|
| Cholinesterase Inhibitors | 6 | 2015 | 43 | 0.280 |
Why?
|
| Myositis, Inclusion Body | 1 | 2006 | 2 | 0.270 |
Why?
|
| Brain Diseases | 5 | 2010 | 32 | 0.270 |
Why?
|
| MSX1 Transcription Factor | 1 | 2005 | 1 | 0.270 |
Why?
|
| Mass Screening | 2 | 2022 | 462 | 0.270 |
Why?
|
| PAX9 Transcription Factor | 1 | 2005 | 4 | 0.270 |
Why?
|
| Butyrylcholinesterase | 2 | 2018 | 5 | 0.270 |
Why?
|
| Protein Multimerization | 2 | 2017 | 103 | 0.270 |
Why?
|
| Streptozocin | 3 | 2022 | 21 | 0.260 |
Why?
|
| Ovum | 6 | 1988 | 35 | 0.260 |
Why?
|
| Cell Line, Tumor | 16 | 2019 | 2231 | 0.260 |
Why?
|
| Acetylcholinesterase | 2 | 2018 | 55 | 0.260 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 7 | 2017 | 306 | 0.260 |
Why?
|
| Heparin | 2 | 2003 | 35 | 0.250 |
Why?
|
| Minority Groups | 2 | 2021 | 596 | 0.250 |
Why?
|
| Hibernation | 4 | 2008 | 7 | 0.250 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 11 | 2009 | 95 | 0.250 |
Why?
|
| Research Design | 4 | 2021 | 313 | 0.250 |
Why?
|
| Trypsin | 2 | 1996 | 38 | 0.250 |
Why?
|
| Presenilin-1 | 6 | 2016 | 27 | 0.250 |
Why?
|
| Chromosome Mapping | 5 | 2021 | 188 | 0.250 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 10 | 2009 | 77 | 0.250 |
Why?
|
| United States | 9 | 2024 | 4223 | 0.250 |
Why?
|
| Trace Elements | 2 | 2002 | 30 | 0.250 |
Why?
|
| Cell Movement | 1 | 2008 | 571 | 0.250 |
Why?
|
| Neuropsychological Tests | 2 | 2022 | 259 | 0.250 |
Why?
|
| Mexico | 5 | 2020 | 240 | 0.250 |
Why?
|
| Antibody Specificity | 8 | 2005 | 79 | 0.250 |
Why?
|
| Longevity | 2 | 2021 | 147 | 0.250 |
Why?
|
| Malondialdehyde | 5 | 2013 | 41 | 0.240 |
Why?
|
| Flavonoids | 2 | 2019 | 87 | 0.240 |
Why?
|
| Dose-Response Relationship, Drug | 13 | 2017 | 1039 | 0.240 |
Why?
|
| Wound Healing | 2 | 2012 | 70 | 0.240 |
Why?
|
| Mitochondrial Membranes | 2 | 2023 | 40 | 0.240 |
Why?
|
| Sp3 Transcription Factor | 1 | 2013 | 8 | 0.240 |
Why?
|
| Frontotemporal Dementia | 1 | 2024 | 4 | 0.240 |
Why?
|
| Eye | 2 | 2018 | 71 | 0.240 |
Why?
|
| Genetic Predisposition to Disease | 4 | 2023 | 628 | 0.240 |
Why?
|
| Adipocytes, Brown | 1 | 2013 | 8 | 0.230 |
Why?
|
| Cross-Linking Reagents | 7 | 2005 | 51 | 0.230 |
Why?
|
| Glycosylation | 10 | 2007 | 100 | 0.230 |
Why?
|
| Ion Channels | 2 | 2013 | 71 | 0.230 |
Why?
|
| Cholesterol | 4 | 2011 | 205 | 0.230 |
Why?
|
| HLA-DR4 Antigen | 1 | 2013 | 20 | 0.230 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2023 | 481 | 0.230 |
Why?
|
| Sp1 Transcription Factor | 1 | 2013 | 48 | 0.230 |
Why?
|
| Heparitin Sulfate | 3 | 2007 | 23 | 0.230 |
Why?
|
| Mitosis | 7 | 2006 | 99 | 0.230 |
Why?
|
| Enzyme Inhibitors | 10 | 2011 | 433 | 0.230 |
Why?
|
| Arteriosclerosis | 4 | 2004 | 36 | 0.230 |
Why?
|
| Glucosephosphate Dehydrogenase | 2 | 2001 | 16 | 0.230 |
Why?
|
| Retina | 2 | 2024 | 280 | 0.230 |
Why?
|
| Neuropil | 3 | 2003 | 6 | 0.230 |
Why?
|
| Air Pollution | 2 | 2016 | 60 | 0.230 |
Why?
|
| Aortic Diseases | 1 | 2003 | 27 | 0.220 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 2013 | 57 | 0.220 |
Why?
|
| beta-Defensins | 2 | 2013 | 4 | 0.220 |
Why?
|
| Amino Acid Sequence | 10 | 2018 | 1180 | 0.220 |
Why?
|
| Mutation | 12 | 2017 | 1095 | 0.220 |
Why?
|
| Russia | 1 | 2023 | 25 | 0.220 |
Why?
|
| Acclimatization | 2 | 2023 | 21 | 0.220 |
Why?
|
| Liver | 6 | 2015 | 479 | 0.220 |
Why?
|
| Edema | 1 | 2023 | 23 | 0.220 |
Why?
|
| Glutathione | 6 | 2017 | 179 | 0.220 |
Why?
|
| Memory Disorders | 2 | 2022 | 73 | 0.220 |
Why?
|
| Antigens | 7 | 2008 | 56 | 0.220 |
Why?
|
| Cultural Diversity | 2 | 2021 | 169 | 0.220 |
Why?
|
| Cerebral Amyloid Angiopathy | 4 | 2004 | 17 | 0.220 |
Why?
|
| Methionine | 3 | 2013 | 30 | 0.220 |
Why?
|
| Child, Preschool | 13 | 2016 | 1418 | 0.220 |
Why?
|
| Receptors, Metabotropic Glutamate | 4 | 2008 | 28 | 0.220 |
Why?
|
| Ribosomes | 2 | 2017 | 32 | 0.220 |
Why?
|
| Water | 4 | 2016 | 296 | 0.210 |
Why?
|
| Amino Acids | 3 | 2021 | 145 | 0.210 |
Why?
|
| Autopsy | 7 | 2019 | 43 | 0.210 |
Why?
|
| Sequence Alignment | 5 | 2018 | 265 | 0.210 |
Why?
|
| Paleopathology | 1 | 2022 | 1 | 0.210 |
Why?
|
| History, Ancient | 1 | 2022 | 12 | 0.210 |
Why?
|
| Bacterial Vaccines | 1 | 2013 | 125 | 0.210 |
Why?
|
| Lipid Peroxides | 4 | 2000 | 17 | 0.210 |
Why?
|
| Frontal Lobe | 8 | 2012 | 48 | 0.210 |
Why?
|
| Tissue Fixation | 2 | 2020 | 17 | 0.210 |
Why?
|
| Calcium-Binding Proteins | 3 | 2019 | 76 | 0.210 |
Why?
|
| Inflammation | 4 | 2024 | 618 | 0.210 |
Why?
|
| Synaptic Transmission | 2 | 2018 | 146 | 0.210 |
Why?
|
| Europe | 1 | 2022 | 101 | 0.210 |
Why?
|
| Estradiol | 2 | 2020 | 262 | 0.210 |
Why?
|
| Growth Inhibitors | 1 | 2001 | 26 | 0.200 |
Why?
|
| Gallium | 1 | 2021 | 2 | 0.200 |
Why?
|
| Rats, Wistar | 8 | 2018 | 233 | 0.200 |
Why?
|
| Pyrroles | 7 | 2000 | 55 | 0.200 |
Why?
|
| Antirheumatic Agents | 1 | 2021 | 31 | 0.200 |
Why?
|
| Isoenzymes | 6 | 2009 | 161 | 0.200 |
Why?
|
| Panama | 1 | 2021 | 5 | 0.200 |
Why?
|
| Analysis of Variance | 6 | 2017 | 550 | 0.200 |
Why?
|
| Publications | 1 | 2021 | 7 | 0.200 |
Why?
|
| Cebus | 1 | 2021 | 4 | 0.200 |
Why?
|
| Fragaria | 1 | 2021 | 1 | 0.200 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2021 | 43 | 0.190 |
Why?
|
| Toll-Like Receptors | 2 | 2020 | 51 | 0.190 |
Why?
|
| Caregivers | 1 | 2024 | 182 | 0.190 |
Why?
|
| Research Personnel | 2 | 2019 | 155 | 0.190 |
Why?
|
| Electrons | 1 | 2021 | 68 | 0.190 |
Why?
|
| Metagenomics | 1 | 2021 | 34 | 0.190 |
Why?
|
| Gliosis | 6 | 2021 | 24 | 0.190 |
Why?
|
| Phenylhydrazines | 4 | 2000 | 4 | 0.190 |
Why?
|
| Sleep | 1 | 2023 | 152 | 0.190 |
Why?
|
| Sea Urchins | 5 | 1985 | 9 | 0.190 |
Why?
|
| Caribbean Region | 1 | 2021 | 69 | 0.190 |
Why?
|
| Microscopy, Electron, Transmission | 6 | 2016 | 146 | 0.190 |
Why?
|
| DNA Fingerprinting | 2 | 2019 | 18 | 0.190 |
Why?
|
| Lymphocytes | 3 | 2021 | 118 | 0.190 |
Why?
|
| Measles-Mumps-Rubella Vaccine | 1 | 2020 | 4 | 0.190 |
Why?
|
| Norleucine | 5 | 2000 | 5 | 0.190 |
Why?
|
| Guidelines as Topic | 2 | 2014 | 54 | 0.190 |
Why?
|
| Tryptophan-tRNA Ligase | 2 | 2018 | 2 | 0.190 |
Why?
|
| Biological Transport | 6 | 2016 | 185 | 0.190 |
Why?
|
| Blotting, Western | 14 | 2015 | 859 | 0.190 |
Why?
|
| Drug Evaluation, Preclinical | 3 | 2017 | 112 | 0.190 |
Why?
|
| Lactoferrin | 1 | 2020 | 4 | 0.190 |
Why?
|
| Salivary Glands | 1 | 2020 | 12 | 0.190 |
Why?
|
| Insemination, Artificial | 1 | 2020 | 9 | 0.190 |
Why?
|
| Calcium | 7 | 2024 | 480 | 0.190 |
Why?
|
| Haplotypes | 1 | 2021 | 182 | 0.180 |
Why?
|
| Blood Vessels | 4 | 2004 | 34 | 0.180 |
Why?
|
| Glial Fibrillary Acidic Protein | 9 | 2022 | 70 | 0.180 |
Why?
|
| Genotype | 7 | 2012 | 730 | 0.180 |
Why?
|
| Life Style | 2 | 2019 | 308 | 0.180 |
Why?
|
| Veterans | 1 | 2021 | 122 | 0.180 |
Why?
|
| Histidine | 3 | 2010 | 42 | 0.180 |
Why?
|
| Arginine | 5 | 2000 | 73 | 0.180 |
Why?
|
| Creutzfeldt-Jakob Syndrome | 2 | 2013 | 28 | 0.180 |
Why?
|
| Early Diagnosis | 2 | 2018 | 64 | 0.180 |
Why?
|
| Rabbits | 8 | 2006 | 283 | 0.180 |
Why?
|
| Vagina | 1 | 2020 | 81 | 0.180 |
Why?
|
| Protein Disulfide-Isomerases | 1 | 2000 | 12 | 0.180 |
Why?
|
| Lipofuscin | 2 | 2011 | 4 | 0.180 |
Why?
|
| Transcription Factors | 3 | 2018 | 681 | 0.180 |
Why?
|
| Excitatory Amino Acid Antagonists | 5 | 2011 | 99 | 0.180 |
Why?
|
| TDP-43 Proteinopathies | 1 | 2019 | 1 | 0.180 |
Why?
|
| Biological Specimen Banks | 1 | 2020 | 25 | 0.180 |
Why?
|
| Regeneration | 1 | 1999 | 20 | 0.180 |
Why?
|
| DNA Degradation, Necrotic | 1 | 2019 | 1 | 0.170 |
Why?
|
| Ginkgo biloba | 1 | 2019 | 3 | 0.170 |
Why?
|
| Gene Flow | 1 | 2019 | 14 | 0.170 |
Why?
|
| Rats, Sprague-Dawley | 11 | 2018 | 1618 | 0.170 |
Why?
|
| Postmortem Changes | 8 | 2012 | 18 | 0.170 |
Why?
|
| Sulfhydryl Compounds | 1 | 1999 | 47 | 0.170 |
Why?
|
| Muscles | 4 | 1994 | 82 | 0.170 |
Why?
|
| Microsatellite Repeats | 1 | 2019 | 59 | 0.170 |
Why?
|
| Brain Stem | 3 | 2011 | 50 | 0.170 |
Why?
|
| Nitrates | 3 | 2003 | 40 | 0.170 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2020 | 90 | 0.170 |
Why?
|
| Tissue Distribution | 7 | 2014 | 207 | 0.170 |
Why?
|
| Sterol Regulatory Element Binding Protein 2 | 1 | 2019 | 5 | 0.170 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2010 | 187 | 0.170 |
Why?
|
| Forensic Pathology | 1 | 2019 | 2 | 0.170 |
Why?
|
| Lithium Chloride | 1 | 2019 | 4 | 0.170 |
Why?
|
| Post-Concussion Syndrome | 1 | 2019 | 4 | 0.170 |
Why?
|
| Physicians | 1 | 2021 | 163 | 0.170 |
Why?
|
| Antimanic Agents | 1 | 2019 | 4 | 0.170 |
Why?
|
| Hydrolases | 1 | 1998 | 15 | 0.170 |
Why?
|
| Cell Membrane Permeability | 2 | 2019 | 52 | 0.170 |
Why?
|
| Acetylglucosamine | 1 | 2018 | 7 | 0.170 |
Why?
|
| Amidohydrolases | 1 | 1998 | 11 | 0.170 |
Why?
|
| Communication | 1 | 2020 | 180 | 0.170 |
Why?
|
| Cardiovascular Diseases | 2 | 2023 | 664 | 0.170 |
Why?
|
| Image Processing, Computer-Assisted | 4 | 2011 | 173 | 0.170 |
Why?
|
| In Situ Hybridization | 6 | 2008 | 129 | 0.170 |
Why?
|
| Mass Spectrometry | 2 | 2018 | 260 | 0.160 |
Why?
|
| Leukocytes, Mononuclear | 2 | 2019 | 234 | 0.160 |
Why?
|
| Behavioral Research | 1 | 2019 | 39 | 0.160 |
Why?
|
| Calcium Compounds | 1 | 2018 | 4 | 0.160 |
Why?
|
| Calpain | 1 | 2019 | 35 | 0.160 |
Why?
|
| Facilitated Diffusion | 1 | 2018 | 2 | 0.160 |
Why?
|
| Tumor Cells, Cultured | 13 | 2005 | 502 | 0.160 |
Why?
|
| Polymorphism, Genetic | 2 | 2010 | 191 | 0.160 |
Why?
|
| Keratins | 5 | 1991 | 25 | 0.160 |
Why?
|
| Endoplasmic Reticulum | 4 | 2015 | 105 | 0.160 |
Why?
|
| Mortality | 1 | 2020 | 145 | 0.160 |
Why?
|
| Occipital Lobe | 1 | 1998 | 5 | 0.160 |
Why?
|
| Risk Assessment | 2 | 2019 | 753 | 0.160 |
Why?
|
| Choroid Plexus | 3 | 2013 | 6 | 0.160 |
Why?
|
| Ethanol | 1 | 2020 | 192 | 0.160 |
Why?
|
| Theta Rhythm | 1 | 2018 | 7 | 0.160 |
Why?
|
| Immune Sera | 8 | 2003 | 59 | 0.160 |
Why?
|
| Chorion | 1 | 2018 | 8 | 0.160 |
Why?
|
| Iron-Sulfur Proteins | 1 | 1998 | 15 | 0.160 |
Why?
|
| Minority Health | 1 | 2019 | 88 | 0.160 |
Why?
|
| Brain Concussion | 1 | 2019 | 29 | 0.160 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 2 | 2009 | 93 | 0.160 |
Why?
|
| Free Radical Scavengers | 3 | 2008 | 66 | 0.160 |
Why?
|
| Hypoxia-Ischemia, Brain | 2 | 2009 | 43 | 0.160 |
Why?
|
| Substance Abuse Detection | 1 | 2018 | 30 | 0.160 |
Why?
|
| Substantia Nigra | 3 | 1999 | 44 | 0.160 |
Why?
|
| Maillard Reaction | 2 | 1994 | 6 | 0.160 |
Why?
|
| Referral and Consultation | 1 | 2019 | 117 | 0.160 |
Why?
|
| Heat-Shock Proteins | 4 | 2011 | 55 | 0.160 |
Why?
|
| Pregnancy | 5 | 2020 | 1549 | 0.160 |
Why?
|
| Depsides | 1 | 2017 | 3 | 0.160 |
Why?
|
| Cell Cycle Proteins | 4 | 2009 | 229 | 0.160 |
Why?
|
| rab GTP-Binding Proteins | 1 | 2018 | 12 | 0.160 |
Why?
|
| Cinnamates | 1 | 2017 | 6 | 0.160 |
Why?
|
| Olea | 1 | 2017 | 1 | 0.150 |
Why?
|
| Stem Cell Transplantation | 1 | 2018 | 31 | 0.150 |
Why?
|
| Glucose Transport Proteins, Facilitative | 1 | 2017 | 14 | 0.150 |
Why?
|
| Microscopy, Electron, Scanning | 5 | 2015 | 142 | 0.150 |
Why?
|
| Cerebellum | 4 | 2006 | 73 | 0.150 |
Why?
|
| Capillaries | 5 | 2008 | 26 | 0.150 |
Why?
|
| Military Personnel | 1 | 2019 | 90 | 0.150 |
Why?
|
| Subcellular Fractions | 4 | 2004 | 77 | 0.150 |
Why?
|
| Treatment Outcome | 2 | 2019 | 1369 | 0.150 |
Why?
|
| Pyridones | 2 | 2009 | 40 | 0.150 |
Why?
|
| Pick Disease of the Brain | 3 | 2007 | 4 | 0.150 |
Why?
|
| Intermediate Filament Proteins | 5 | 1991 | 13 | 0.150 |
Why?
|
| Cytoprotection | 2 | 2009 | 36 | 0.150 |
Why?
|
| Plants | 2 | 2016 | 99 | 0.150 |
Why?
|
| Caspase 3 | 3 | 2015 | 207 | 0.150 |
Why?
|
| Spectrum Analysis | 2 | 2016 | 54 | 0.150 |
Why?
|
| DNA Fragmentation | 5 | 2019 | 92 | 0.150 |
Why?
|
| Databases, Bibliographic | 2 | 2015 | 9 | 0.150 |
Why?
|
| Molecular Structure | 6 | 2017 | 492 | 0.150 |
Why?
|
| Cytoskeletal Proteins | 4 | 1996 | 105 | 0.150 |
Why?
|
| Dogs | 3 | 2016 | 149 | 0.150 |
Why?
|
| Homocysteine | 3 | 2008 | 19 | 0.150 |
Why?
|
| Maze Learning | 4 | 2013 | 105 | 0.150 |
Why?
|
| Neurosciences | 1 | 1997 | 28 | 0.150 |
Why?
|
| Anthocyanins | 1 | 2017 | 5 | 0.150 |
Why?
|
| Tretinoin | 2 | 2009 | 50 | 0.150 |
Why?
|
| DNA Primers | 2 | 2008 | 286 | 0.150 |
Why?
|
| Biomimetic Materials | 1 | 2017 | 23 | 0.150 |
Why?
|
| Estrogen Replacement Therapy | 4 | 2006 | 44 | 0.150 |
Why?
|
| Membrane Transport Proteins | 3 | 2012 | 95 | 0.150 |
Why?
|
| Deep Brain Stimulation | 1 | 2017 | 9 | 0.150 |
Why?
|
| Mice, Inbred Strains | 3 | 2013 | 116 | 0.140 |
Why?
|
| Receptors, Nicotinic | 1 | 2018 | 106 | 0.140 |
Why?
|
| Stem Cells | 1 | 2018 | 141 | 0.140 |
Why?
|
| Chitin | 2 | 2007 | 19 | 0.140 |
Why?
|
| Terminology as Topic | 1 | 2017 | 34 | 0.140 |
Why?
|
| Neuritis | 1 | 2016 | 2 | 0.140 |
Why?
|
| Drug Stability | 1 | 2017 | 116 | 0.140 |
Why?
|
| Estrogen Receptor alpha | 2 | 2016 | 111 | 0.140 |
Why?
|
| RNA-Binding Proteins | 1 | 1998 | 146 | 0.140 |
Why?
|
| Leishmania | 1 | 2016 | 17 | 0.140 |
Why?
|
| Holography | 1 | 2016 | 3 | 0.140 |
Why?
|
| Glycogen Synthase Kinase 3 | 3 | 2006 | 32 | 0.140 |
Why?
|
| Host-Pathogen Interactions | 1 | 2018 | 186 | 0.140 |
Why?
|
| Ascorbic Acid | 5 | 2017 | 66 | 0.140 |
Why?
|
| Neurotoxicity Syndromes | 2 | 2007 | 35 | 0.140 |
Why?
|
| Heterocyclic Compounds | 1 | 2016 | 21 | 0.140 |
Why?
|
| Mice, Knockout | 7 | 2018 | 933 | 0.140 |
Why?
|
| Action Potentials | 1 | 2018 | 231 | 0.140 |
Why?
|
| Medicare | 1 | 2018 | 195 | 0.140 |
Why?
|
| Propylene Glycols | 1 | 2016 | 4 | 0.140 |
Why?
|
| Antiprotozoal Agents | 1 | 2016 | 30 | 0.140 |
Why?
|
| Cohort Studies | 3 | 2015 | 1492 | 0.140 |
Why?
|
| Aquaporins | 1 | 2016 | 17 | 0.140 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2017 | 110 | 0.140 |
Why?
|
| alpha 1-Antichymotrypsin | 2 | 1993 | 2 | 0.130 |
Why?
|
| Evidence-Based Medicine | 1 | 2016 | 97 | 0.130 |
Why?
|
| Basal Ganglia | 1 | 1995 | 17 | 0.130 |
Why?
|
| Dynamins | 5 | 2017 | 16 | 0.130 |
Why?
|
| Models, Chemical | 1 | 2017 | 207 | 0.130 |
Why?
|
| Fertilization | 4 | 1985 | 38 | 0.130 |
Why?
|
| Polymerase Chain Reaction | 5 | 2010 | 448 | 0.130 |
Why?
|
| Pharmacogenetics | 1 | 2016 | 49 | 0.130 |
Why?
|
| Ribonucleases | 3 | 2005 | 30 | 0.130 |
Why?
|
| Proteoglycans | 2 | 1992 | 47 | 0.130 |
Why?
|
| Brain Injury, Chronic | 1 | 2015 | 1 | 0.130 |
Why?
|
| Glyceraldehyde | 1 | 1995 | 3 | 0.130 |
Why?
|
| Pentanoic Acids | 1 | 2015 | 2 | 0.130 |
Why?
|
| Ribose | 1 | 1995 | 11 | 0.130 |
Why?
|
| Solubility | 4 | 2016 | 118 | 0.130 |
Why?
|
| Developing Countries | 1 | 2016 | 99 | 0.130 |
Why?
|
| Cell Size | 2 | 2007 | 44 | 0.130 |
Why?
|
| Chlamydophila pneumoniae | 1 | 2015 | 8 | 0.130 |
Why?
|
| Communicable Diseases | 1 | 2016 | 45 | 0.130 |
Why?
|
| BRCA1 Protein | 2 | 2023 | 48 | 0.130 |
Why?
|
| Gonadotropins, Pituitary | 2 | 2005 | 2 | 0.130 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2015 | 75 | 0.130 |
Why?
|
| Chromosomes, Human, X | 1 | 2015 | 22 | 0.130 |
Why?
|
| Insulin-Secreting Cells | 1 | 2015 | 28 | 0.130 |
Why?
|
| Aneuploidy | 1 | 2015 | 23 | 0.130 |
Why?
|
| Hydrocephalus | 2 | 2006 | 16 | 0.130 |
Why?
|
| Uric Acid | 2 | 2017 | 26 | 0.130 |
Why?
|
| Fluorescent Antibody Technique | 11 | 2011 | 189 | 0.130 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 5 | 2013 | 623 | 0.120 |
Why?
|
| Alleles | 2 | 2012 | 321 | 0.120 |
Why?
|
| Drug Discovery | 2 | 2018 | 82 | 0.120 |
Why?
|
| Coumarins | 1 | 2015 | 38 | 0.120 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 3 | 2005 | 99 | 0.120 |
Why?
|
| Mast Cells | 1 | 2015 | 81 | 0.120 |
Why?
|
| Type C Phospholipases | 4 | 1995 | 21 | 0.120 |
Why?
|
| Escherichia coli | 1 | 2017 | 453 | 0.120 |
Why?
|
| Selenoproteins | 1 | 2017 | 159 | 0.120 |
Why?
|
| Faculty, Medical | 1 | 2015 | 66 | 0.120 |
Why?
|
| Young Adult | 9 | 2019 | 4268 | 0.120 |
Why?
|
| Hospitalization | 1 | 2018 | 388 | 0.120 |
Why?
|
| Membrane Potential, Mitochondrial | 4 | 2017 | 84 | 0.120 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 3 | 2013 | 84 | 0.120 |
Why?
|
| Transition Elements | 2 | 2012 | 3 | 0.120 |
Why?
|
| Mice, Inbred BALB C | 8 | 2016 | 661 | 0.120 |
Why?
|
| Prefrontal Cortex | 1 | 2016 | 137 | 0.120 |
Why?
|
| Body Weight | 2 | 2015 | 434 | 0.120 |
Why?
|
| Recombinant Proteins | 3 | 2012 | 515 | 0.120 |
Why?
|
| Nanostructures | 2 | 2006 | 134 | 0.120 |
Why?
|
| Central Nervous System Diseases | 2 | 2012 | 29 | 0.120 |
Why?
|
| Heme | 3 | 2005 | 70 | 0.120 |
Why?
|
| Locus Coeruleus | 2 | 1996 | 15 | 0.120 |
Why?
|
| Acute-Phase Proteins | 1 | 1993 | 14 | 0.120 |
Why?
|
| Apolipoprotein E3 | 1 | 2013 | 10 | 0.120 |
Why?
|
| Protein Structure, Secondary | 5 | 2020 | 183 | 0.120 |
Why?
|
| Muscle, Smooth, Vascular | 2 | 2001 | 130 | 0.120 |
Why?
|
| Cytoplasmic Granules | 2 | 2011 | 8 | 0.120 |
Why?
|
| Macrophages | 2 | 2016 | 439 | 0.120 |
Why?
|
| Antithrombin III | 1 | 1993 | 4 | 0.120 |
Why?
|
| Protein Isoforms | 2 | 2023 | 130 | 0.120 |
Why?
|
| Receptors, Leptin | 1 | 2013 | 13 | 0.120 |
Why?
|
| NF-kappa B | 2 | 2010 | 339 | 0.120 |
Why?
|
| Molecular Weight | 7 | 2013 | 167 | 0.120 |
Why?
|
| Ischemic Attack, Transient | 1 | 1993 | 20 | 0.120 |
Why?
|
| Chemokines | 1 | 2014 | 97 | 0.110 |
Why?
|
| Sequence Deletion | 2 | 2004 | 87 | 0.110 |
Why?
|
| In Situ Hybridization, Fluorescence | 2 | 2015 | 53 | 0.110 |
Why?
|
| KCNQ2 Potassium Channel | 1 | 2013 | 3 | 0.110 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 2 | 2003 | 29 | 0.110 |
Why?
|
| DNA Mutational Analysis | 3 | 2010 | 93 | 0.110 |
Why?
|
| Cysteine Proteinase Inhibitors | 2 | 2005 | 22 | 0.110 |
Why?
|
| Pineal Gland | 2 | 1990 | 31 | 0.110 |
Why?
|
| DNA Glycosylases | 1 | 2013 | 16 | 0.110 |
Why?
|
| Embryonic and Fetal Development | 1 | 1993 | 37 | 0.110 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2019 | 807 | 0.110 |
Why?
|
| Cyclin-Dependent Kinases | 2 | 2004 | 27 | 0.110 |
Why?
|
| Transferrin | 1 | 2013 | 40 | 0.110 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 1993 | 70 | 0.110 |
Why?
|
| Monoamine Oxidase | 1 | 2013 | 34 | 0.110 |
Why?
|
| Centromere | 1 | 2013 | 21 | 0.110 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2013 | 44 | 0.110 |
Why?
|
| Ischemic Preconditioning | 2 | 2011 | 48 | 0.110 |
Why?
|
| Infant | 6 | 2016 | 1046 | 0.110 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 2012 | 28 | 0.110 |
Why?
|
| Gene Amplification | 1 | 2012 | 26 | 0.110 |
Why?
|
| Hydroxyl Radical | 4 | 2010 | 15 | 0.110 |
Why?
|
| Guanine | 2 | 2003 | 45 | 0.110 |
Why?
|
| Arachidonic Acids | 3 | 1988 | 24 | 0.110 |
Why?
|
| Fluorescence | 1 | 2013 | 121 | 0.110 |
Why?
|
| Diabetes Mellitus, Experimental | 2 | 2011 | 94 | 0.110 |
Why?
|
| Caspases | 4 | 2003 | 147 | 0.110 |
Why?
|
| Neuropharmacology | 2 | 2009 | 2 | 0.110 |
Why?
|
| Nucleic Acid Hybridization | 3 | 2008 | 69 | 0.110 |
Why?
|
| Drug Therapy, Combination | 2 | 2015 | 227 | 0.110 |
Why?
|
| Blood Glucose | 2 | 2013 | 353 | 0.110 |
Why?
|
| Texas | 1 | 2014 | 324 | 0.110 |
Why?
|
| alpha 1-Antitrypsin | 1 | 1992 | 7 | 0.100 |
Why?
|
| Presenilins | 5 | 2010 | 6 | 0.100 |
Why?
|
| Animals, Newborn | 7 | 2014 | 343 | 0.100 |
Why?
|
| Sensitivity and Specificity | 3 | 2023 | 562 | 0.100 |
Why?
|
| Retrograde Degeneration | 1 | 2011 | 1 | 0.100 |
Why?
|
| Septal Nuclei | 1 | 2011 | 3 | 0.100 |
Why?
|
| Microscopy, Fluorescence | 5 | 2017 | 252 | 0.100 |
Why?
|
| Madagascar | 1 | 2011 | 7 | 0.100 |
Why?
|
| Endangered Species | 1 | 2011 | 10 | 0.100 |
Why?
|
| Receptors, Immunologic | 2 | 2010 | 61 | 0.100 |
Why?
|
| Neurobiology | 1 | 2011 | 1 | 0.100 |
Why?
|
| Ribosomal Protein S6 | 1 | 2011 | 2 | 0.100 |
Why?
|
| Immunoglobulin G | 2 | 2010 | 237 | 0.100 |
Why?
|
| Biological Assay | 1 | 2012 | 59 | 0.100 |
Why?
|
| Nucleotides | 1 | 2011 | 36 | 0.100 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 1993 | 182 | 0.100 |
Why?
|
| Antineoplastic Agents | 1 | 2019 | 803 | 0.100 |
Why?
|
| Plant Lectins | 1 | 1991 | 4 | 0.100 |
Why?
|
| Organometallic Compounds | 1 | 2012 | 73 | 0.100 |
Why?
|
| Gene Expression Regulation, Enzymologic | 3 | 2009 | 168 | 0.100 |
Why?
|
| Antimicrobial Cationic Peptides | 1 | 2012 | 35 | 0.100 |
Why?
|
| Open Reading Frames | 1 | 2011 | 77 | 0.100 |
Why?
|
| Cerebral Hemorrhage | 2 | 2003 | 103 | 0.100 |
Why?
|
| G-Protein-Coupled Receptor Kinase 2 | 2 | 2008 | 6 | 0.100 |
Why?
|
| Positron-Emission Tomography | 2 | 2023 | 80 | 0.100 |
Why?
|
| Drug Compounding | 1 | 2012 | 76 | 0.100 |
Why?
|
| Extracellular Space | 1 | 1991 | 35 | 0.100 |
Why?
|
| Macaca mulatta | 2 | 2008 | 128 | 0.100 |
Why?
|
| Hormone Replacement Therapy | 3 | 2006 | 41 | 0.100 |
Why?
|
| Microtubule Proteins | 2 | 1988 | 4 | 0.100 |
Why?
|
| Geography | 1 | 2011 | 96 | 0.100 |
Why?
|
| Nitric Oxide Synthase Type II | 4 | 2005 | 115 | 0.100 |
Why?
|
| Sciuridae | 3 | 2008 | 5 | 0.100 |
Why?
|
| Retinoblastoma Protein | 1 | 2011 | 27 | 0.100 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 3 | 2008 | 121 | 0.100 |
Why?
|
| Central Nervous System Agents | 1 | 2011 | 7 | 0.100 |
Why?
|
| 1-Methyl-4-phenylpyridinium | 1 | 2011 | 30 | 0.100 |
Why?
|
| Pituitary Gland | 4 | 2018 | 63 | 0.100 |
Why?
|
| T-Lymphocytes | 1 | 1993 | 357 | 0.090 |
Why?
|
| Hypochlorous Acid | 1 | 2010 | 3 | 0.090 |
Why?
|
| Substance-Related Disorders | 1 | 2018 | 730 | 0.090 |
Why?
|
| Vimentin | 2 | 1990 | 37 | 0.090 |
Why?
|
| Nonlinear Dynamics | 1 | 2010 | 33 | 0.090 |
Why?
|
| Peptide Hydrolases | 1 | 2010 | 40 | 0.090 |
Why?
|
| Fertility Agents, Female | 2 | 2007 | 6 | 0.090 |
Why?
|
| Flow Cytometry | 4 | 2021 | 399 | 0.090 |
Why?
|
| Mathematics | 1 | 2010 | 48 | 0.090 |
Why?
|
| Actins | 5 | 2006 | 148 | 0.090 |
Why?
|
| Oligodendroglioma | 1 | 1990 | 5 | 0.090 |
Why?
|
| Calmodulin-Binding Proteins | 1 | 2010 | 6 | 0.090 |
Why?
|
| Diet, Mediterranean | 1 | 2010 | 40 | 0.090 |
Why?
|
| Neocortex | 3 | 2006 | 27 | 0.090 |
Why?
|
| Microscopy, Confocal | 5 | 2015 | 218 | 0.090 |
Why?
|
| Amino Acid Substitution | 2 | 2012 | 132 | 0.090 |
Why?
|
| Astrocytoma | 1 | 1990 | 14 | 0.090 |
Why?
|
| Antigens, Differentiation | 1 | 1990 | 25 | 0.090 |
Why?
|
| Kynurenine | 1 | 2010 | 7 | 0.090 |
Why?
|
| Memantine | 1 | 2009 | 4 | 0.090 |
Why?
|
| Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2010 | 7 | 0.090 |
Why?
|
| Oxidative Phosphorylation | 2 | 2010 | 53 | 0.090 |
Why?
|
| Embryo, Mammalian | 5 | 2010 | 153 | 0.090 |
Why?
|
| Retrospective Studies | 3 | 2021 | 2026 | 0.090 |
Why?
|
| Uganda | 2 | 2019 | 22 | 0.090 |
Why?
|
| Polymers | 3 | 2005 | 121 | 0.090 |
Why?
|
| Rats, Inbred Strains | 5 | 2000 | 133 | 0.090 |
Why?
|
| 5-Aminolevulinate Synthetase | 1 | 2009 | 1 | 0.090 |
Why?
|
| Infant, Newborn | 7 | 2014 | 894 | 0.090 |
Why?
|
| Parkinson Disease, Secondary | 1 | 1989 | 10 | 0.090 |
Why?
|
| Iron Metabolism Disorders | 1 | 2009 | 3 | 0.090 |
Why?
|
| Receptors, LDL | 2 | 2012 | 30 | 0.090 |
Why?
|
| MAP Kinase Kinase 4 | 4 | 2012 | 31 | 0.090 |
Why?
|
| Growth | 1 | 2009 | 12 | 0.080 |
Why?
|
| Infarction, Middle Cerebral Artery | 2 | 2007 | 77 | 0.080 |
Why?
|
| Phlebotomy | 1 | 2009 | 5 | 0.080 |
Why?
|
| Heredodegenerative Disorders, Nervous System | 1 | 2009 | 2 | 0.080 |
Why?
|
| Hypoxia, Brain | 1 | 2009 | 7 | 0.080 |
Why?
|
| Oxygen Consumption | 5 | 2013 | 103 | 0.080 |
Why?
|
| Cell Differentiation | 4 | 2018 | 587 | 0.080 |
Why?
|
| Brain Diseases, Metabolic | 1 | 1989 | 1 | 0.080 |
Why?
|
| Leigh Disease | 1 | 1989 | 1 | 0.080 |
Why?
|
| Glioblastoma | 1 | 1990 | 55 | 0.080 |
Why?
|
| Nuclear Proteins | 4 | 2019 | 307 | 0.080 |
Why?
|
| Spinal Cord Diseases | 1 | 1989 | 5 | 0.080 |
Why?
|
| Peptides | 3 | 2021 | 320 | 0.080 |
Why?
|
| Genes, myc | 1 | 2009 | 29 | 0.080 |
Why?
|
| Carbohydrate Metabolism | 2 | 2003 | 21 | 0.080 |
Why?
|
| Vacuoles | 2 | 2003 | 25 | 0.080 |
Why?
|
| Cacao | 1 | 2008 | 10 | 0.080 |
Why?
|
| S Phase | 1 | 2009 | 37 | 0.080 |
Why?
|
| Immunoprecipitation | 2 | 2009 | 131 | 0.080 |
Why?
|
| Asphyxia Neonatorum | 1 | 2008 | 5 | 0.080 |
Why?
|
| Caloric Restriction | 1 | 2009 | 32 | 0.080 |
Why?
|
| Blotting, Northern | 3 | 2005 | 150 | 0.080 |
Why?
|
| Resuscitation | 1 | 2008 | 17 | 0.080 |
Why?
|
| Filgrastim | 1 | 2008 | 2 | 0.080 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2008 | 17 | 0.080 |
Why?
|
| Histone Deacetylases | 1 | 2009 | 56 | 0.080 |
Why?
|
| Respiration, Artificial | 1 | 2008 | 39 | 0.080 |
Why?
|
| Autoantibodies | 1 | 2009 | 103 | 0.080 |
Why?
|
| Regional Blood Flow | 1 | 2008 | 40 | 0.080 |
Why?
|
| Iron Compounds | 1 | 2008 | 4 | 0.080 |
Why?
|
| Potyvirus | 1 | 2008 | 5 | 0.080 |
Why?
|
| Histones | 3 | 2007 | 190 | 0.080 |
Why?
|
| Mitochondria, Muscle | 2 | 2006 | 16 | 0.080 |
Why?
|
| Blood Flow Velocity | 1 | 2008 | 61 | 0.080 |
Why?
|
| Densitometry | 2 | 2000 | 13 | 0.080 |
Why?
|
| Multiple Sclerosis | 2 | 2007 | 45 | 0.080 |
Why?
|
| Staining and Labeling | 7 | 1993 | 105 | 0.080 |
Why?
|
| Acetylcarnitine | 1 | 2008 | 8 | 0.080 |
Why?
|
| Metal Metabolism, Inborn Errors | 1 | 2008 | 1 | 0.080 |
Why?
|
| Chromosomes, Human | 1 | 2008 | 35 | 0.080 |
Why?
|
| Urochordata | 1 | 1988 | 2 | 0.080 |
Why?
|
| Central Nervous System | 2 | 2007 | 135 | 0.080 |
Why?
|
| Stress, Psychological | 1 | 2014 | 583 | 0.080 |
Why?
|
| Cysteine Endopeptidases | 4 | 2004 | 59 | 0.080 |
Why?
|
| Hydrostatic Pressure | 1 | 2007 | 7 | 0.080 |
Why?
|
| Demyelinating Diseases | 2 | 1998 | 15 | 0.080 |
Why?
|
| Exercise | 1 | 2013 | 613 | 0.080 |
Why?
|
| Eukaryotic Cells | 1 | 2007 | 36 | 0.080 |
Why?
|
| Starch | 1 | 2007 | 12 | 0.080 |
Why?
|
| Ubiquinone | 2 | 2010 | 22 | 0.080 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2007 | 26 | 0.080 |
Why?
|
| Menopause | 1 | 2008 | 56 | 0.080 |
Why?
|
| Retinal Diseases | 1 | 2007 | 17 | 0.080 |
Why?
|
| Optic Nerve Diseases | 1 | 2007 | 26 | 0.080 |
Why?
|
| Rats, Inbred F344 | 4 | 2009 | 245 | 0.080 |
Why?
|
| Age Factors | 5 | 2012 | 1033 | 0.080 |
Why?
|
| Permeability | 3 | 2016 | 67 | 0.080 |
Why?
|
| Interleukin-6 | 2 | 2001 | 153 | 0.080 |
Why?
|
| Nerve Growth Factor | 2 | 2008 | 30 | 0.080 |
Why?
|
| Lithium Compounds | 1 | 2007 | 3 | 0.080 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2008 | 84 | 0.080 |
Why?
|
| Research Support as Topic | 2 | 2019 | 80 | 0.070 |
Why?
|
| Retinal Ganglion Cells | 1 | 2007 | 44 | 0.070 |
Why?
|
| Organelles | 1 | 2007 | 24 | 0.070 |
Why?
|
| Polysaccharides | 1 | 2007 | 58 | 0.070 |
Why?
|
| Muscle Proteins | 2 | 2003 | 51 | 0.070 |
Why?
|
| Data Interpretation, Statistical | 1 | 2007 | 111 | 0.070 |
Why?
|
| Metabolomics | 2 | 2021 | 81 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 2007 | 26 | 0.070 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2007 | 22 | 0.070 |
Why?
|
| Pan paniscus | 1 | 2007 | 1 | 0.070 |
Why?
|
| Xanthomatosis, Cerebrotendinous | 1 | 2007 | 1 | 0.070 |
Why?
|
| Gorilla gorilla | 1 | 2007 | 4 | 0.070 |
Why?
|
| Mesencephalon | 3 | 2002 | 41 | 0.070 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2006 | 295 | 0.070 |
Why?
|
| Genomic Imprinting | 1 | 2007 | 35 | 0.070 |
Why?
|
| Hypoglycemic Agents | 1 | 2009 | 160 | 0.070 |
Why?
|
| Smad2 Protein | 1 | 2006 | 8 | 0.070 |
Why?
|
| Hypothalamo-Hypophyseal System | 2 | 2004 | 53 | 0.070 |
Why?
|
| alpha Karyopherins | 1 | 2006 | 3 | 0.070 |
Why?
|
| Retinoblastoma-Like Protein p130 | 1 | 2006 | 1 | 0.070 |
Why?
|
| Osteopontin | 1 | 2007 | 36 | 0.070 |
Why?
|
| beta-Adrenergic Receptor Kinases | 1 | 2006 | 2 | 0.070 |
Why?
|
| Immunologic Techniques | 4 | 2008 | 11 | 0.070 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 4 | 2009 | 448 | 0.070 |
Why?
|
| Family | 1 | 2008 | 173 | 0.070 |
Why?
|
| Water Pollution, Chemical | 1 | 2006 | 10 | 0.070 |
Why?
|
| Cholinergic Antagonists | 1 | 2006 | 8 | 0.070 |
Why?
|
| RNA Interference | 3 | 2012 | 243 | 0.070 |
Why?
|
| Spleen | 4 | 2015 | 199 | 0.070 |
Why?
|
| Glaucoma | 1 | 2007 | 85 | 0.070 |
Why?
|
| Catechols | 1 | 2006 | 5 | 0.070 |
Why?
|
| Muscular Dystrophy, Animal | 1 | 1986 | 3 | 0.070 |
Why?
|
| Ubiquitin | 2 | 2004 | 78 | 0.070 |
Why?
|
| Atherosclerosis | 1 | 2008 | 134 | 0.070 |
Why?
|
| Spinal Cord | 4 | 1991 | 94 | 0.070 |
Why?
|
| Clusterin | 1 | 2006 | 9 | 0.070 |
Why?
|
| Muscle Cells | 1 | 2006 | 11 | 0.070 |
Why?
|
| Energy Intake | 1 | 2007 | 170 | 0.070 |
Why?
|
| Inflammation Mediators | 2 | 2021 | 123 | 0.070 |
Why?
|
| Recombination, Genetic | 1 | 2006 | 93 | 0.070 |
Why?
|
| Immunity, Innate | 2 | 2020 | 149 | 0.070 |
Why?
|
| Likelihood Functions | 1 | 2005 | 59 | 0.070 |
Why?
|
| Glioma | 1 | 2006 | 79 | 0.070 |
Why?
|
| Choline O-Acetyltransferase | 2 | 2018 | 34 | 0.070 |
Why?
|
| Structure-Activity Relationship | 2 | 2017 | 409 | 0.070 |
Why?
|
| Carnosine | 1 | 2005 | 1 | 0.070 |
Why?
|
| Antigen-Antibody Complex | 4 | 2009 | 19 | 0.070 |
Why?
|
| Financial Support | 1 | 2005 | 7 | 0.070 |
Why?
|
| Adenosine Triphosphate | 3 | 2011 | 196 | 0.070 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2006 | 93 | 0.070 |
Why?
|
| Cell Physiological Phenomena | 1 | 2005 | 9 | 0.060 |
Why?
|
| Arachidonic Acid | 4 | 2003 | 35 | 0.060 |
Why?
|
| Biology | 1 | 2005 | 16 | 0.060 |
Why?
|
| Biotechnology | 1 | 2005 | 15 | 0.060 |
Why?
|
| Tandem Mass Spectrometry | 2 | 2018 | 182 | 0.060 |
Why?
|
| Phagocytosis | 3 | 2003 | 69 | 0.060 |
Why?
|
| Synucleins | 2 | 2004 | 6 | 0.060 |
Why?
|
| Cricetinae | 2 | 2013 | 238 | 0.060 |
Why?
|
| Cell Count | 3 | 2007 | 135 | 0.060 |
Why?
|
| Transforming Growth Factor beta | 1 | 2006 | 197 | 0.060 |
Why?
|
| Academies and Institutes | 1 | 2005 | 37 | 0.060 |
Why?
|
| Amino Acid Motifs | 1 | 2005 | 91 | 0.060 |
Why?
|
| Ribosomal Protein S6 Kinases, 90-kDa | 1 | 2005 | 22 | 0.060 |
Why?
|
| Iron Regulatory Protein 2 | 2 | 2010 | 2 | 0.060 |
Why?
|
| Quinones | 1 | 2004 | 14 | 0.060 |
Why?
|
| Time | 1 | 2004 | 14 | 0.060 |
Why?
|
| Biopolymers | 1 | 2004 | 18 | 0.060 |
Why?
|
| Iron Regulatory Protein 1 | 2 | 2010 | 5 | 0.060 |
Why?
|
| Hyperlipoproteinemia Type II | 1 | 2004 | 4 | 0.060 |
Why?
|
| X-Rays | 2 | 2018 | 18 | 0.060 |
Why?
|
| PrPSc Proteins | 1 | 2004 | 2 | 0.060 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2003 | 190 | 0.060 |
Why?
|
| Scrapie | 1 | 2004 | 14 | 0.060 |
Why?
|
| Ice Cover | 1 | 2024 | 2 | 0.060 |
Why?
|
| Peroxidases | 1 | 2004 | 15 | 0.060 |
Why?
|
| Radioimmunotherapy | 1 | 2024 | 2 | 0.060 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 1 | 2005 | 54 | 0.060 |
Why?
|
| Transcription, Genetic | 3 | 2011 | 578 | 0.060 |
Why?
|
| Models, Animal | 2 | 2002 | 134 | 0.060 |
Why?
|
| Cyclin B | 1 | 2004 | 7 | 0.060 |
Why?
|
| Acid Phosphatase | 2 | 1995 | 21 | 0.060 |
Why?
|
| Phodopus | 1 | 2013 | 3 | 0.060 |
Why?
|
| Myogenin | 1 | 2013 | 5 | 0.060 |
Why?
|
| MyoD Protein | 1 | 2013 | 9 | 0.060 |
Why?
|
| Cyclins | 1 | 2004 | 37 | 0.060 |
Why?
|
| Genetic Testing | 2 | 2018 | 75 | 0.060 |
Why?
|
| Biopsy | 2 | 2003 | 164 | 0.060 |
Why?
|
| p300-CBP Transcription Factors | 1 | 2013 | 10 | 0.060 |
Why?
|
| Aluminum | 2 | 2006 | 36 | 0.060 |
Why?
|
| Chemical Precipitation | 1 | 2003 | 8 | 0.060 |
Why?
|
| Reproduction | 2 | 2020 | 71 | 0.060 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 2 | 2018 | 35 | 0.060 |
Why?
|
| Dopamine | 1 | 2005 | 245 | 0.060 |
Why?
|
| Asthma | 1 | 2008 | 380 | 0.060 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2013 | 62 | 0.060 |
Why?
|
| Wiskott-Aldrich Syndrome | 1 | 2003 | 4 | 0.060 |
Why?
|
| Introns | 1 | 2013 | 75 | 0.060 |
Why?
|
| Drug Antagonism | 1 | 2003 | 5 | 0.060 |
Why?
|
| Glutathione Peroxidase | 2 | 2001 | 111 | 0.060 |
Why?
|
| Practice Guidelines as Topic | 1 | 2004 | 191 | 0.060 |
Why?
|
| Pneumonia, Bacterial | 1 | 2013 | 22 | 0.060 |
Why?
|
| Aorta | 2 | 2004 | 167 | 0.060 |
Why?
|
| Biological Transport, Active | 3 | 2016 | 26 | 0.060 |
Why?
|
| PPAR gamma | 1 | 2013 | 53 | 0.060 |
Why?
|
| Severity of Illness Index | 2 | 2020 | 610 | 0.060 |
Why?
|
| Estrogen Receptor Modulators | 1 | 2003 | 19 | 0.060 |
Why?
|
| NAD(P)H Dehydrogenase (Quinone) | 1 | 2003 | 16 | 0.060 |
Why?
|
| Blood Proteins | 2 | 2017 | 66 | 0.060 |
Why?
|
| Consensus | 1 | 2023 | 45 | 0.060 |
Why?
|
| BRCA2 Protein | 1 | 2023 | 37 | 0.060 |
Why?
|
| Microfilament Proteins | 1 | 2003 | 69 | 0.060 |
Why?
|
| Random Allocation | 3 | 2008 | 139 | 0.060 |
Why?
|
| Gene Knockdown Techniques | 1 | 2013 | 173 | 0.060 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2023 | 54 | 0.060 |
Why?
|
| Phosphatidylinositols | 2 | 1993 | 12 | 0.060 |
Why?
|
| Physiology, Comparative | 1 | 2002 | 1 | 0.060 |
Why?
|
| Causality | 2 | 2019 | 44 | 0.060 |
Why?
|
| Chlamydia trachomatis | 1 | 2013 | 68 | 0.060 |
Why?
|
| Muscular Diseases | 1 | 2003 | 20 | 0.060 |
Why?
|
| Acrolein | 1 | 2003 | 16 | 0.060 |
Why?
|
| Mendelian Randomization Analysis | 1 | 2023 | 12 | 0.060 |
Why?
|
| Animal Feed | 1 | 2003 | 43 | 0.050 |
Why?
|
| Threonine | 2 | 2018 | 25 | 0.050 |
Why?
|
| Electron Transport Chain Complex Proteins | 2 | 2015 | 12 | 0.050 |
Why?
|
| Deoxyribonucleases | 1 | 2002 | 25 | 0.050 |
Why?
|
| Tamoxifen | 1 | 2003 | 65 | 0.050 |
Why?
|
| Body Temperature | 1 | 2002 | 36 | 0.050 |
Why?
|
| HMGB1 Protein | 1 | 2003 | 29 | 0.050 |
Why?
|
| Chlamydia muridarum | 1 | 2013 | 104 | 0.050 |
Why?
|
| Protein Folding | 1 | 2003 | 127 | 0.050 |
Why?
|
| Presynaptic Terminals | 1 | 2023 | 53 | 0.050 |
Why?
|
| Respiratory Burst | 1 | 2002 | 4 | 0.050 |
Why?
|
| Receptors, Glutamate | 1 | 2002 | 27 | 0.050 |
Why?
|
| Iodine Radioisotopes | 1 | 2002 | 35 | 0.050 |
Why?
|
| Anticoagulants | 1 | 2003 | 102 | 0.050 |
Why?
|
| Succinates | 1 | 2022 | 3 | 0.050 |
Why?
|
| Intracranial Hemorrhages | 1 | 2002 | 26 | 0.050 |
Why?
|
| Lipid Metabolism | 2 | 2017 | 119 | 0.050 |
Why?
|
| Lactates | 1 | 2022 | 8 | 0.050 |
Why?
|
| Disulfides | 2 | 2000 | 77 | 0.050 |
Why?
|
| Glutamates | 1 | 2022 | 22 | 0.050 |
Why?
|
| Feedback | 4 | 2007 | 53 | 0.050 |
Why?
|
| Interferon-gamma | 1 | 2013 | 250 | 0.050 |
Why?
|
| Molecular Chaperones | 1 | 2002 | 61 | 0.050 |
Why?
|
| Inositol | 1 | 2022 | 21 | 0.050 |
Why?
|
| Metals, Heavy | 1 | 2003 | 60 | 0.050 |
Why?
|
| Heparan Sulfate Proteoglycans | 2 | 1992 | 12 | 0.050 |
Why?
|
| Multiple System Atrophy | 1 | 2002 | 2 | 0.050 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 5 | 2001 | 201 | 0.050 |
Why?
|
| United States Food and Drug Administration | 1 | 2022 | 22 | 0.050 |
Why?
|
| Drug Approval | 1 | 2022 | 8 | 0.050 |
Why?
|
| Cytochalasin B | 2 | 1988 | 4 | 0.050 |
Why?
|
| Ganglia, Spinal | 2 | 1993 | 37 | 0.050 |
Why?
|
| Cadaver | 1 | 2002 | 42 | 0.050 |
Why?
|
| Indium | 1 | 2021 | 1 | 0.050 |
Why?
|
| Apoptosis Regulatory Proteins | 2 | 2004 | 147 | 0.050 |
Why?
|
| Mutation, Missense | 2 | 2012 | 83 | 0.050 |
Why?
|
| N-Methylaspartate | 1 | 2002 | 57 | 0.050 |
Why?
|
| Propensity Score | 1 | 2021 | 38 | 0.050 |
Why?
|
| NADPH-Ferrihemoprotein Reductase | 1 | 2001 | 9 | 0.050 |
Why?
|
| Protein Transport | 3 | 2009 | 302 | 0.050 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2013 | 259 | 0.050 |
Why?
|
| Aorta, Thoracic | 1 | 2001 | 28 | 0.050 |
Why?
|
| Computer Simulation | 2 | 2016 | 362 | 0.050 |
Why?
|
| Tunica Intima | 1 | 2001 | 19 | 0.050 |
Why?
|
| Sodium Dodecyl Sulfate | 2 | 2004 | 21 | 0.050 |
Why?
|
| Serotonin | 1 | 2002 | 123 | 0.050 |
Why?
|
| Goiter, Nodular | 1 | 2001 | 2 | 0.050 |
Why?
|
| Hyperlipidemias | 1 | 2001 | 36 | 0.050 |
Why?
|
| Models, Molecular | 3 | 2016 | 808 | 0.050 |
Why?
|
| Zygote | 1 | 1981 | 39 | 0.050 |
Why?
|
| Interleukin-1 | 1 | 2001 | 35 | 0.050 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2003 | 194 | 0.050 |
Why?
|
| 2,4-Dichlorophenoxyacetic Acid | 1 | 2001 | 1 | 0.050 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2001 | 68 | 0.050 |
Why?
|
| Hypothyroidism | 1 | 2001 | 18 | 0.050 |
Why?
|
| Purkinje Cells | 1 | 2001 | 20 | 0.050 |
Why?
|
| Protein Structure, Tertiary | 2 | 2012 | 408 | 0.050 |
Why?
|
| Testis | 2 | 1993 | 187 | 0.050 |
Why?
|
| Bradykinin | 1 | 2001 | 22 | 0.050 |
Why?
|
| Glutathione Reductase | 1 | 2001 | 23 | 0.050 |
Why?
|
| Neuronal Plasticity | 1 | 2022 | 103 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 9 | 1 | 2000 | 7 | 0.050 |
Why?
|
| Drug Interactions | 2 | 2005 | 141 | 0.050 |
Why?
|
| Receptors, LH | 3 | 2007 | 4 | 0.050 |
Why?
|
| Prognosis | 2 | 2017 | 739 | 0.050 |
Why?
|
| Naphthoquinones | 1 | 1981 | 36 | 0.050 |
Why?
|
| Comorbidity | 1 | 2023 | 623 | 0.050 |
Why?
|
| Follicle Stimulating Hormone | 2 | 2015 | 43 | 0.050 |
Why?
|
| Cholesterol, Dietary | 1 | 2000 | 10 | 0.050 |
Why?
|
| Membrane Lipids | 1 | 2001 | 33 | 0.050 |
Why?
|
| Muscle, Smooth | 1 | 2001 | 58 | 0.050 |
Why?
|
| Intercellular Junctions | 2 | 1990 | 17 | 0.050 |
Why?
|
| Bronchi | 1 | 2001 | 46 | 0.050 |
Why?
|
| Estrus Synchronization | 1 | 2020 | 1 | 0.050 |
Why?
|
| Cell Membrane | 3 | 2000 | 381 | 0.050 |
Why?
|
| Faculty | 1 | 2021 | 94 | 0.050 |
Why?
|
| Catalase | 1 | 2001 | 109 | 0.050 |
Why?
|
| Herbicides | 1 | 2001 | 44 | 0.050 |
Why?
|
| Animals, Genetically Modified | 2 | 2002 | 99 | 0.050 |
Why?
|
| Deferoxamine | 3 | 2010 | 19 | 0.050 |
Why?
|
| Medicine in Literature | 1 | 2020 | 2 | 0.050 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2000 | 16 | 0.050 |
Why?
|
| RNA, Bacterial | 1 | 2020 | 33 | 0.050 |
Why?
|
| Technetium | 1 | 2000 | 11 | 0.050 |
Why?
|
| Drosophila Proteins | 1 | 2002 | 171 | 0.050 |
Why?
|
| Lysosomes | 2 | 2015 | 91 | 0.050 |
Why?
|
| Fertility | 1 | 2020 | 59 | 0.040 |
Why?
|
| Mentors | 1 | 2021 | 127 | 0.040 |
Why?
|
| Pentose Phosphate Pathway | 1 | 1999 | 2 | 0.040 |
Why?
|
| Cell Fractionation | 2 | 1998 | 30 | 0.040 |
Why?
|
| Progesterone | 1 | 2020 | 113 | 0.040 |
Why?
|
| Freezing | 1 | 1999 | 16 | 0.040 |
Why?
|
| Gabon | 1 | 2019 | 1 | 0.040 |
Why?
|
| Trust | 1 | 2021 | 133 | 0.040 |
Why?
|
| Drug Synergism | 1 | 2020 | 177 | 0.040 |
Why?
|
| Forensic Genetics | 1 | 2019 | 2 | 0.040 |
Why?
|
| Forensic Anthropology | 1 | 2019 | 2 | 0.040 |
Why?
|
| Cameroon | 1 | 2019 | 38 | 0.040 |
Why?
|
| Protein Kinases | 2 | 2015 | 100 | 0.040 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2020 | 171 | 0.040 |
Why?
|
| Program Evaluation | 1 | 2021 | 339 | 0.040 |
Why?
|
| Hydrogen-Ion Concentration | 4 | 1985 | 364 | 0.040 |
Why?
|
| Aspartic Acid | 2 | 2013 | 47 | 0.040 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2019 | 49 | 0.040 |
Why?
|
| Food Deprivation | 1 | 1999 | 30 | 0.040 |
Why?
|
| Quinone Reductases | 1 | 1999 | 1 | 0.040 |
Why?
|
| Liver Neoplasms | 1 | 2002 | 190 | 0.040 |
Why?
|
| Vitamin E | 3 | 2006 | 61 | 0.040 |
Why?
|
| Gene Knock-In Techniques | 1 | 2019 | 14 | 0.040 |
Why?
|
| Acylation | 1 | 2018 | 10 | 0.040 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2020 | 214 | 0.040 |
Why?
|
| Cysteine | 3 | 2005 | 98 | 0.040 |
Why?
|
| Creatine Kinase, BB Form | 1 | 2018 | 1 | 0.040 |
Why?
|
| Gestational Age | 3 | 1998 | 190 | 0.040 |
Why?
|
| Coculture Techniques | 2 | 2015 | 101 | 0.040 |
Why?
|
| Microsomes | 1 | 1998 | 52 | 0.040 |
Why?
|
| Synchrotrons | 1 | 2018 | 6 | 0.040 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 1998 | 28 | 0.040 |
Why?
|
| Phosphopyruvate Hydratase | 1 | 2018 | 33 | 0.040 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2019 | 67 | 0.040 |
Why?
|
| Genetic Markers | 2 | 2010 | 142 | 0.040 |
Why?
|
| Precipitin Tests | 2 | 1999 | 52 | 0.040 |
Why?
|
| Iron-Regulatory Proteins | 1 | 1998 | 2 | 0.040 |
Why?
|
| Polypharmacy | 1 | 2018 | 25 | 0.040 |
Why?
|
| Papio hamadryas | 1 | 2018 | 3 | 0.040 |
Why?
|
| Spermatozoa | 1 | 1980 | 200 | 0.040 |
Why?
|
| Adenosine Triphosphatases | 1 | 1998 | 82 | 0.040 |
Why?
|
| Prosencephalon | 1 | 2018 | 25 | 0.040 |
Why?
|
| Receptors, Somatotropin | 1 | 2018 | 12 | 0.040 |
Why?
|
| Salts | 1 | 2018 | 16 | 0.040 |
Why?
|
| Rosmarinus | 1 | 2017 | 1 | 0.040 |
Why?
|
| Gait Disorders, Neurologic | 1 | 2018 | 11 | 0.040 |
Why?
|
| Tremor | 1 | 2018 | 9 | 0.040 |
Why?
|
| Quinazolinones | 1 | 2017 | 6 | 0.040 |
Why?
|
| Vibration | 1 | 2017 | 23 | 0.040 |
Why?
|
| Doxycycline | 1 | 2018 | 30 | 0.040 |
Why?
|
| Magnetic Resonance Spectroscopy | 2 | 2010 | 289 | 0.040 |
Why?
|
| Trans-Activators | 2 | 2011 | 174 | 0.040 |
Why?
|
| Recovery of Function | 1 | 2018 | 88 | 0.040 |
Why?
|
| Health Services Needs and Demand | 1 | 2019 | 146 | 0.040 |
Why?
|
| Prostaglandins E | 1 | 1997 | 3 | 0.040 |
Why?
|
| Tocopherols | 1 | 2017 | 65 | 0.040 |
Why?
|
| Extracellular Matrix | 1 | 1998 | 115 | 0.040 |
Why?
|
| Doxorubicin | 1 | 2017 | 84 | 0.040 |
Why?
|
| Leucine | 1 | 2017 | 29 | 0.040 |
Why?
|
| Repressor Proteins | 1 | 2019 | 249 | 0.040 |
Why?
|
| Lectins | 2 | 1998 | 20 | 0.040 |
Why?
|
| Proline | 1 | 2017 | 43 | 0.040 |
Why?
|
| Lipoproteins, LDL | 1 | 1997 | 62 | 0.040 |
Why?
|
| Proto-Oncogene Proteins | 3 | 2005 | 239 | 0.040 |
Why?
|
| Parasitic Sensitivity Tests | 1 | 2016 | 14 | 0.040 |
Why?
|
| Nitric Oxide Synthase Type I | 3 | 2001 | 56 | 0.040 |
Why?
|
| Lipoxygenase | 3 | 1985 | 5 | 0.040 |
Why?
|
| Public Health | 1 | 2021 | 372 | 0.040 |
Why?
|
| Multiprotein Complexes | 2 | 2007 | 54 | 0.030 |
Why?
|
| Alkalies | 1 | 1996 | 5 | 0.030 |
Why?
|
| Formates | 1 | 1996 | 5 | 0.030 |
Why?
|
| Hemostatics | 1 | 1996 | 8 | 0.030 |
Why?
|
| Guanidine | 1 | 1996 | 13 | 0.030 |
Why?
|
| Microscopy | 2 | 2009 | 32 | 0.030 |
Why?
|
| Protein Denaturation | 1 | 1996 | 43 | 0.030 |
Why?
|
| Guanidines | 1 | 1996 | 17 | 0.030 |
Why?
|
| Colorectal Neoplasms | 1 | 2002 | 441 | 0.030 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2016 | 37 | 0.030 |
Why?
|
| Alternative Splicing | 1 | 2016 | 85 | 0.030 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2016 | 88 | 0.030 |
Why?
|
| Gene Frequency | 2 | 2012 | 195 | 0.030 |
Why?
|
| Urea | 1 | 1996 | 41 | 0.030 |
Why?
|
| Interleukin-10 | 1 | 2016 | 75 | 0.030 |
Why?
|
| Glutamic Acid | 2 | 2010 | 128 | 0.030 |
Why?
|
| Algorithms | 2 | 2011 | 465 | 0.030 |
Why?
|
| Serum Amyloid A Protein | 1 | 1995 | 14 | 0.030 |
Why?
|
| Life Expectancy | 1 | 1996 | 42 | 0.030 |
Why?
|
| Oligopeptides | 2 | 2013 | 102 | 0.030 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2008 | 77 | 0.030 |
Why?
|
| Hormone Antagonists | 2 | 2006 | 14 | 0.030 |
Why?
|
| Crystallography, X-Ray | 1 | 2016 | 265 | 0.030 |
Why?
|
| Vegetables | 1 | 2017 | 147 | 0.030 |
Why?
|
| Fetus | 2 | 1993 | 105 | 0.030 |
Why?
|
| Point Mutation | 2 | 2006 | 93 | 0.030 |
Why?
|
| Calmodulin | 2 | 1987 | 46 | 0.030 |
Why?
|
| Cell Proliferation | 2 | 2012 | 1198 | 0.030 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2015 | 20 | 0.030 |
Why?
|
| Caspase 1 | 1 | 2015 | 15 | 0.030 |
Why?
|
| Diabetes Complications | 1 | 1996 | 90 | 0.030 |
Why?
|
| Fruit | 1 | 2017 | 173 | 0.030 |
Why?
|
| In Situ Nick-End Labeling | 2 | 2007 | 133 | 0.030 |
Why?
|
| Hypothalamus | 2 | 2006 | 129 | 0.030 |
Why?
|
| Mice, Obese | 1 | 2015 | 40 | 0.030 |
Why?
|
| Biotin | 2 | 2009 | 24 | 0.030 |
Why?
|
| Cytosol | 3 | 2004 | 93 | 0.030 |
Why?
|
| Mental Disorders | 1 | 2019 | 309 | 0.030 |
Why?
|
| Interleukin-1beta | 1 | 2015 | 70 | 0.030 |
Why?
|
| Delayed-Action Preparations | 1 | 2015 | 60 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2018 | 885 | 0.030 |
Why?
|
| Chickens | 2 | 1986 | 133 | 0.030 |
Why?
|
| Receptors, Cell Surface | 3 | 2002 | 144 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 1 | 2018 | 352 | 0.030 |
Why?
|
| RNA, Small Interfering | 1 | 2017 | 409 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2015 | 286 | 0.030 |
Why?
|
| Amino Acid Chloromethyl Ketones | 1 | 2013 | 8 | 0.030 |
Why?
|
| Protozoan Proteins | 1 | 2016 | 182 | 0.030 |
Why?
|
| Blood-Testis Barrier | 1 | 1993 | 3 | 0.030 |
Why?
|
| Interleukin-7 | 1 | 1993 | 7 | 0.030 |
Why?
|
| Desmin | 1 | 1993 | 2 | 0.030 |
Why?
|
| Complement System Proteins | 1 | 1993 | 21 | 0.030 |
Why?
|
| Actinin | 1 | 1993 | 8 | 0.030 |
Why?
|
| Phosphoric Diester Hydrolases | 1 | 1993 | 19 | 0.030 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2015 | 253 | 0.030 |
Why?
|
| Urban Population | 1 | 2016 | 333 | 0.030 |
Why?
|
| Ferrous Compounds | 2 | 2006 | 20 | 0.030 |
Why?
|
| Postmenopause | 2 | 2005 | 128 | 0.030 |
Why?
|
| Glutathione Disulfide | 1 | 2013 | 8 | 0.030 |
Why?
|
| Ependyma | 2 | 1991 | 5 | 0.030 |
Why?
|
| Cyanides | 2 | 1985 | 11 | 0.030 |
Why?
|
| Adenine Nucleotides | 1 | 2013 | 6 | 0.030 |
Why?
|
| Bone Marrow Cells | 1 | 1993 | 81 | 0.030 |
Why?
|
| Escape Reaction | 1 | 2013 | 15 | 0.030 |
Why?
|
| Neurons, Afferent | 1 | 1993 | 43 | 0.030 |
Why?
|
| Muscular Dystrophies | 1 | 1993 | 2 | 0.030 |
Why?
|
| Cell Nucleus Division | 1 | 2013 | 1 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase 5 | 2 | 2004 | 8 | 0.030 |
Why?
|
| Myositis | 1 | 1993 | 7 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2021 | 2721 | 0.030 |
Why?
|
| Thymus Gland | 1 | 1993 | 81 | 0.030 |
Why?
|
| Chromosomal Instability | 1 | 2013 | 22 | 0.030 |
Why?
|
| Interpersonal Relations | 1 | 2015 | 205 | 0.030 |
Why?
|
| Lactic Acid | 1 | 2013 | 95 | 0.030 |
Why?
|
| Incidence | 1 | 1996 | 922 | 0.030 |
Why?
|
| Presenilin-2 | 2 | 2004 | 2 | 0.030 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2012 | 26 | 0.030 |
Why?
|
| Radioimmunoassay | 2 | 2004 | 65 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2014 | 291 | 0.030 |
Why?
|
| Reaction Time | 1 | 2013 | 143 | 0.030 |
Why?
|
| Lymphocyte Activation | 1 | 1993 | 236 | 0.030 |
Why?
|
| Tetrazolium Salts | 1 | 2012 | 36 | 0.030 |
Why?
|
| Pentetic Acid | 2 | 2004 | 4 | 0.030 |
Why?
|
| Epithelium | 2 | 1990 | 79 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2005 | 269 | 0.030 |
Why?
|
| Health Status Disparities | 1 | 2019 | 642 | 0.030 |
Why?
|
| MAP Kinase Kinase 6 | 2 | 2002 | 2 | 0.030 |
Why?
|
| Multienzyme Complexes | 2 | 2004 | 69 | 0.030 |
Why?
|
| Glycolipids | 1 | 1992 | 9 | 0.030 |
Why?
|
| Neoplasm Metastasis | 1 | 1993 | 219 | 0.030 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2012 | 70 | 0.030 |
Why?
|
| Adaptive Immunity | 1 | 2012 | 27 | 0.030 |
Why?
|
| Methanol | 1 | 1992 | 18 | 0.030 |
Why?
|
| Nuclear Respiratory Factors | 1 | 2011 | 1 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinase 8 | 2 | 2003 | 12 | 0.030 |
Why?
|
| Thiazoles | 1 | 2012 | 74 | 0.030 |
Why?
|
| CREB-Binding Protein | 1 | 2011 | 13 | 0.030 |
Why?
|
| Malaria, Cerebral | 1 | 1992 | 31 | 0.030 |
Why?
|
| Chemotaxis | 1 | 2012 | 60 | 0.030 |
Why?
|
| Tissue Culture Techniques | 1 | 2011 | 32 | 0.030 |
Why?
|
| Mutant Proteins | 1 | 2012 | 51 | 0.030 |
Why?
|
| Proteasome Endopeptidase Complex | 2 | 2004 | 114 | 0.030 |
Why?
|
| Okadaic Acid | 2 | 2002 | 15 | 0.030 |
Why?
|
| Neutrophils | 2 | 2000 | 131 | 0.030 |
Why?
|
| Fluoresceins | 2 | 2007 | 27 | 0.020 |
Why?
|
| Adenosine Diphosphate | 1 | 2011 | 21 | 0.020 |
Why?
|
| Dendritic Cells | 1 | 2012 | 113 | 0.020 |
Why?
|
| Meninges | 1 | 1991 | 6 | 0.020 |
Why?
|
| Nasal Mucosa | 1 | 1991 | 29 | 0.020 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 2011 | 78 | 0.020 |
Why?
|
| Silver | 1 | 1991 | 54 | 0.020 |
Why?
|
| Injections, Intraventricular | 1 | 2011 | 64 | 0.020 |
Why?
|
| Gene Regulatory Networks | 1 | 2012 | 120 | 0.020 |
Why?
|
| Genetic Vectors | 1 | 2011 | 158 | 0.020 |
Why?
|
| Nitric Oxide Synthase Type III | 2 | 2001 | 67 | 0.020 |
Why?
|
| Guanosine Diphosphate | 1 | 2010 | 12 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 9 | 2 | 2001 | 3 | 0.020 |
Why?
|
| Brain Ischemia | 1 | 1993 | 184 | 0.020 |
Why?
|
| Luminol | 1 | 2010 | 1 | 0.020 |
Why?
|
| Guanosine Triphosphate | 1 | 2010 | 18 | 0.020 |
Why?
|
| Insulin Resistance | 1 | 2012 | 184 | 0.020 |
Why?
|
| Amnesia | 1 | 2010 | 8 | 0.020 |
Why?
|
| Luminescent Measurements | 1 | 2010 | 26 | 0.020 |
Why?
|
| Stress, Physiological | 1 | 2012 | 150 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2011 | 151 | 0.020 |
Why?
|
| Bile Canaliculi | 1 | 1990 | 1 | 0.020 |
Why?
|
| Ethylnitrosourea | 1 | 1990 | 2 | 0.020 |
Why?
|
| Bile Ducts, Intrahepatic | 1 | 1990 | 4 | 0.020 |
Why?
|
| Fluorescent Dyes | 1 | 2011 | 181 | 0.020 |
Why?
|
| Formaldehyde | 1 | 2010 | 33 | 0.020 |
Why?
|
| Citric Acid Cycle | 1 | 2010 | 6 | 0.020 |
Why?
|
| Receptors, AMPA | 1 | 2010 | 56 | 0.020 |
Why?
|
| Probability | 1 | 2010 | 78 | 0.020 |
Why?
|
| Peroxidase | 1 | 2010 | 49 | 0.020 |
Why?
|
| Rodentia | 1 | 2010 | 43 | 0.020 |
Why?
|
| Subacute Sclerosing Panencephalitis | 1 | 1989 | 1 | 0.020 |
Why?
|
| Microinjections | 2 | 2003 | 57 | 0.020 |
Why?
|
| Spain | 1 | 2010 | 36 | 0.020 |
Why?
|
| Benzoates | 1 | 2010 | 16 | 0.020 |
Why?
|
| Protective Agents | 1 | 2010 | 25 | 0.020 |
Why?
|
| Electron Transport | 1 | 2010 | 40 | 0.020 |
Why?
|
| Hypoxia-Inducible Factor 1 | 1 | 2010 | 11 | 0.020 |
Why?
|
| Buthionine Sulfoximine | 1 | 2009 | 12 | 0.020 |
Why?
|
| Antiparkinson Agents | 1 | 2009 | 12 | 0.020 |
Why?
|
| Protein Phosphatase 2 | 1 | 2009 | 22 | 0.020 |
Why?
|
| Calcium Signaling | 1 | 2011 | 101 | 0.020 |
Why?
|
| Amygdala | 1 | 1990 | 114 | 0.020 |
Why?
|
| Congresses as Topic | 1 | 2010 | 42 | 0.020 |
Why?
|
| Luminescent Proteins | 1 | 2010 | 77 | 0.020 |
Why?
|
| Age of Onset | 1 | 2010 | 100 | 0.020 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2010 | 86 | 0.020 |
Why?
|
| Dimerization | 1 | 2009 | 112 | 0.020 |
Why?
|
| Concept Formation | 1 | 2009 | 20 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 2 | 2003 | 152 | 0.020 |
Why?
|
| Seroepidemiologic Studies | 1 | 2009 | 68 | 0.020 |
Why?
|
| Cyclooxygenase 1 | 1 | 2009 | 11 | 0.020 |
Why?
|
| Hydroxymethylbilane Synthase | 1 | 2009 | 1 | 0.020 |
Why?
|
| Porphobilinogen Synthase | 1 | 2009 | 4 | 0.020 |
Why?
|
| Thiobarbituric Acid Reactive Substances | 2 | 2000 | 15 | 0.020 |
Why?
|
| Ferritins | 1 | 2010 | 55 | 0.020 |
Why?
|
| Uncoupling Agents | 1 | 2009 | 3 | 0.020 |
Why?
|
| Boronic Acids | 1 | 2009 | 19 | 0.020 |
Why?
|
| Collagen Type XI | 1 | 2009 | 2 | 0.020 |
Why?
|
| Mitochondrial Membrane Transport Proteins | 1 | 2009 | 33 | 0.020 |
Why?
|
| Acetylation | 1 | 2009 | 98 | 0.020 |
Why?
|
| Triazoles | 1 | 2010 | 86 | 0.020 |
Why?
|
| Electron Transport Complex I | 1 | 2009 | 21 | 0.020 |
Why?
|
| Protein Subunits | 1 | 2009 | 87 | 0.020 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2009 | 62 | 0.020 |
Why?
|
| Neurotoxins | 1 | 2009 | 57 | 0.020 |
Why?
|
| Selenium | 2 | 2001 | 148 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 1989 | 217 | 0.020 |
Why?
|
| Catechin | 1 | 2008 | 31 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2009 | 208 | 0.020 |
Why?
|
| S100 Proteins | 2 | 2001 | 12 | 0.020 |
Why?
|
| Electron Probe Microanalysis | 1 | 2008 | 13 | 0.020 |
Why?
|
| Prostatic Neoplasms | 1 | 2018 | 935 | 0.020 |
Why?
|
| Macrophage Activation | 1 | 2008 | 56 | 0.020 |
Why?
|
| Schistosoma mansoni | 1 | 1988 | 18 | 0.020 |
Why?
|
| Brain Diseases, Metabolic, Inborn | 1 | 2008 | 1 | 0.020 |
Why?
|
| Gene Duplication | 1 | 2008 | 24 | 0.020 |
Why?
|
| Phagosomes | 1 | 2007 | 30 | 0.020 |
Why?
|
| Quantitative Trait Loci | 1 | 2008 | 77 | 0.020 |
Why?
|
| Cell Line, Transformed | 1 | 2007 | 91 | 0.020 |
Why?
|
| Phosphatidylcholines | 1 | 2007 | 47 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2010 | 974 | 0.020 |
Why?
|
| Sp Transcription Factors | 1 | 2007 | 1 | 0.020 |
Why?
|
| Synteny | 1 | 2007 | 15 | 0.020 |
Why?
|
| Extraembryonic Membranes | 1 | 2007 | 6 | 0.020 |
Why?
|
| Luteinizing Hormone, beta Subunit | 1 | 2007 | 1 | 0.020 |
Why?
|
| Models, Theoretical | 1 | 2009 | 217 | 0.020 |
Why?
|
| Achilles Tendon | 1 | 2007 | 2 | 0.020 |
Why?
|
| Transgenes | 2 | 1998 | 59 | 0.020 |
Why?
|
| Syndrome | 1 | 2007 | 74 | 0.020 |
Why?
|
| Abnormalities, Multiple | 1 | 2007 | 36 | 0.020 |
Why?
|
| Intraocular Pressure | 1 | 2007 | 112 | 0.020 |
Why?
|
| Euchromatin | 1 | 2006 | 6 | 0.020 |
Why?
|
| False Negative Reactions | 1 | 2006 | 9 | 0.020 |
Why?
|
| Fatal Outcome | 1 | 2007 | 40 | 0.020 |
Why?
|
| Smad Proteins | 1 | 2006 | 12 | 0.020 |
Why?
|
| False Positive Reactions | 1 | 2006 | 26 | 0.020 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2006 | 14 | 0.020 |
Why?
|
| Membrane Glycoproteins | 2 | 2002 | 211 | 0.020 |
Why?
|
| Gonads | 1 | 2006 | 20 | 0.020 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2007 | 118 | 0.020 |
Why?
|
| CpG Islands | 1 | 2007 | 97 | 0.020 |
Why?
|
| Phospholipids | 1 | 2007 | 70 | 0.020 |
Why?
|
| Organoids | 1 | 1987 | 22 | 0.020 |
Why?
|
| Linkage Disequilibrium | 1 | 2006 | 85 | 0.020 |
Why?
|
| Cell Division | 2 | 2000 | 307 | 0.020 |
Why?
|
| Autistic Disorder | 1 | 2007 | 37 | 0.020 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2009 | 213 | 0.020 |
Why?
|
| Apolipoprotein A-I | 1 | 2006 | 21 | 0.020 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 2006 | 78 | 0.020 |
Why?
|
| Necrosis | 1 | 2006 | 49 | 0.020 |
Why?
|
| Software | 1 | 2008 | 217 | 0.020 |
Why?
|
| Mutagenesis | 2 | 1999 | 89 | 0.020 |
Why?
|
| Hypercholesterolemia | 1 | 2006 | 38 | 0.020 |
Why?
|
| Intracellular Membranes | 1 | 2006 | 38 | 0.020 |
Why?
|
| Monophenol Monooxygenase | 1 | 2006 | 14 | 0.020 |
Why?
|
| Drinking | 1 | 2006 | 38 | 0.020 |
Why?
|
| Drug Therapy | 1 | 2006 | 17 | 0.020 |
Why?
|
| Comet Assay | 1 | 2006 | 76 | 0.020 |
Why?
|
| Brain Edema | 1 | 2006 | 63 | 0.020 |
Why?
|
| Benzenesulfonates | 1 | 2005 | 8 | 0.020 |
Why?
|
| Hydroquinones | 1 | 2005 | 8 | 0.020 |
Why?
|
| Butylamines | 1 | 2005 | 2 | 0.020 |
Why?
|
| Schiff Bases | 1 | 2005 | 5 | 0.020 |
Why?
|
| Gold | 1 | 1987 | 136 | 0.020 |
Why?
|
| Chile | 1 | 2005 | 6 | 0.020 |
Why?
|
| Indicators and Reagents | 1 | 2005 | 58 | 0.020 |
Why?
|
| Membrane Potentials | 1 | 2006 | 223 | 0.020 |
Why?
|
| Benzoquinones | 1 | 2005 | 36 | 0.020 |
Why?
|
| Spectrophotometry, Ultraviolet | 1 | 2005 | 98 | 0.020 |
Why?
|
| Risk Reduction Behavior | 1 | 2006 | 127 | 0.020 |
Why?
|
| Financing, Government | 1 | 2005 | 19 | 0.020 |
Why?
|
| Alkylation | 1 | 2005 | 11 | 0.020 |
Why?
|
| Isotretinoin | 1 | 2005 | 4 | 0.020 |
Why?
|
| Hydroxyeicosatetraenoic Acids | 1 | 1985 | 9 | 0.020 |
Why?
|
| Enzyme Activators | 1 | 2005 | 12 | 0.020 |
Why?
|
| Phospholipases A | 1 | 1985 | 10 | 0.020 |
Why?
|
| Netherlands | 1 | 2004 | 10 | 0.020 |
Why?
|
| Frozen Sections | 2 | 1999 | 7 | 0.020 |
Why?
|
| 3T3 Cells | 1 | 2004 | 59 | 0.020 |
Why?
|
| Atrophy | 1 | 2005 | 42 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2007 | 286 | 0.020 |
Why?
|
| Arousal | 1 | 2005 | 86 | 0.020 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 1985 | 34 | 0.020 |
Why?
|
| STAT1 Transcription Factor | 1 | 2005 | 35 | 0.020 |
Why?
|
| Serine | 1 | 2005 | 75 | 0.020 |
Why?
|
| Premenopause | 1 | 2005 | 104 | 0.020 |
Why?
|
| Carbon Monoxide | 1 | 2004 | 34 | 0.020 |
Why?
|
| Ovary | 1 | 2005 | 108 | 0.020 |
Why?
|
| Nitric Oxide Donors | 1 | 2004 | 18 | 0.020 |
Why?
|
| Cystathionine beta-Synthase | 1 | 2004 | 12 | 0.020 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 1984 | 22 | 0.020 |
Why?
|
| Chymotrypsin | 1 | 2004 | 15 | 0.020 |
Why?
|
| Women's Health | 1 | 2005 | 145 | 0.020 |
Why?
|
| Matched-Pair Analysis | 1 | 2004 | 9 | 0.020 |
Why?
|
| Cyclin B1 | 1 | 2004 | 16 | 0.010 |
Why?
|
| G2 Phase | 1 | 2004 | 29 | 0.010 |
Why?
|
| Serine Endopeptidases | 1 | 2004 | 38 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2004 | 55 | 0.010 |
Why?
|
| Hemoglobins | 1 | 2004 | 107 | 0.010 |
Why?
|
| Proteomics | 1 | 2006 | 325 | 0.010 |
Why?
|
| Forecasting | 1 | 2004 | 128 | 0.010 |
Why?
|
| Wiskott-Aldrich Syndrome Protein Family | 1 | 2003 | 2 | 0.010 |
Why?
|
| Wiskott-Aldrich Syndrome Protein, Neuronal | 1 | 2003 | 4 | 0.010 |
Why?
|
| Myocardium | 1 | 1986 | 235 | 0.010 |
Why?
|
| Memory | 1 | 2005 | 170 | 0.010 |
Why?
|
| Antibody Formation | 1 | 1983 | 74 | 0.010 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 2003 | 14 | 0.010 |
Why?
|
| Staurosporine | 1 | 2003 | 38 | 0.010 |
Why?
|
| DNA Methylation | 1 | 2007 | 325 | 0.010 |
Why?
|
| Xeroderma Pigmentosum Group A Protein | 1 | 2003 | 3 | 0.010 |
Why?
|
| Depression, Chemical | 1 | 2003 | 4 | 0.010 |
Why?
|
| Phosphothreonine | 1 | 2003 | 5 | 0.010 |
Why?
|
| Stimulation, Chemical | 1 | 2003 | 22 | 0.010 |
Why?
|
| Second Messenger Systems | 1 | 2003 | 14 | 0.010 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2003 | 59 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2006 | 935 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2003 | 21 | 0.010 |
Why?
|
| Deoxyadenosines | 1 | 2003 | 9 | 0.010 |
Why?
|
| Meningitis | 1 | 2003 | 8 | 0.010 |
Why?
|
| Lithium | 1 | 2003 | 15 | 0.010 |
Why?
|
| Immunization, Passive | 1 | 2003 | 19 | 0.010 |
Why?
|
| Cell Compartmentation | 1 | 2003 | 13 | 0.010 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2004 | 132 | 0.010 |
Why?
|
| Estrogen Receptor beta | 1 | 2003 | 40 | 0.010 |
Why?
|
| Flocculation | 1 | 2002 | 6 | 0.010 |
Why?
|
| Cytochromes | 1 | 2002 | 4 | 0.010 |
Why?
|
| Coenzymes | 1 | 2002 | 13 | 0.010 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2003 | 29 | 0.010 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2004 | 208 | 0.010 |
Why?
|
| DNA Probes | 1 | 2002 | 29 | 0.010 |
Why?
|
| Receptors, Kainic Acid | 1 | 2002 | 11 | 0.010 |
Why?
|
| Metalloproteins | 1 | 2002 | 25 | 0.010 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2003 | 64 | 0.010 |
Why?
|
| Cerebral Amyloid Angiopathy, Familial | 1 | 2002 | 3 | 0.010 |
Why?
|
| Sympathetic Nervous System | 1 | 2003 | 74 | 0.010 |
Why?
|
| Radionuclide Imaging | 1 | 2002 | 28 | 0.010 |
Why?
|
| Nervous System | 1 | 2002 | 29 | 0.010 |
Why?
|
| 5-Methoxytryptamine | 1 | 2002 | 2 | 0.010 |
Why?
|
| Administration, Intranasal | 1 | 2002 | 79 | 0.010 |
Why?
|
| Nitrogen Oxides | 1 | 2002 | 5 | 0.010 |
Why?
|
| Imidazoles | 1 | 2003 | 126 | 0.010 |
Why?
|
| Dietary Fats | 1 | 2003 | 119 | 0.010 |
Why?
|
| Pyridines | 1 | 2003 | 116 | 0.010 |
Why?
|
| Survival Rate | 1 | 2003 | 311 | 0.010 |
Why?
|
| Spectrum Analysis, Raman | 1 | 2003 | 88 | 0.010 |
Why?
|
| Autoantigens | 1 | 2002 | 81 | 0.010 |
Why?
|
| Receptors, Melatonin | 1 | 2002 | 12 | 0.010 |
Why?
|
| Cyclic N-Oxides | 1 | 2002 | 18 | 0.010 |
Why?
|
| Receptors, Estrogen | 1 | 2003 | 156 | 0.010 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2002 | 47 | 0.010 |
Why?
|
| Immunochemistry | 2 | 1995 | 9 | 0.010 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2002 | 59 | 0.010 |
Why?
|
| I-kappa B Proteins | 1 | 2001 | 41 | 0.010 |
Why?
|
| Dihydrolipoamide Dehydrogenase | 1 | 2001 | 2 | 0.010 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2002 | 47 | 0.010 |
Why?
|
| Transcription Factor RelA | 1 | 2001 | 40 | 0.010 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2002 | 62 | 0.010 |
Why?
|
| Pigments, Biological | 1 | 1981 | 10 | 0.010 |
Why?
|
| Testosterone | 1 | 2002 | 193 | 0.010 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2002 | 137 | 0.010 |
Why?
|
| Serum Albumin, Bovine | 1 | 2001 | 51 | 0.010 |
Why?
|
| Enzyme Induction | 1 | 2001 | 53 | 0.010 |
Why?
|
| Hepatocytes | 1 | 2002 | 75 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2001 | 103 | 0.010 |
Why?
|
| Heterozygote | 1 | 2001 | 93 | 0.010 |
Why?
|
| Leukocyte Count | 1 | 2001 | 77 | 0.010 |
Why?
|
| Thyroxine | 1 | 2001 | 19 | 0.010 |
Why?
|
| Muscle Development | 1 | 2001 | 45 | 0.010 |
Why?
|
| Culture Media, Conditioned | 1 | 2001 | 46 | 0.010 |
Why?
|
| Nitrites | 1 | 2001 | 46 | 0.010 |
Why?
|
| Chaperonin 60 | 1 | 2001 | 18 | 0.010 |
Why?
|
| Thyrotropin | 1 | 2001 | 17 | 0.010 |
Why?
|
| Isoelectric Point | 1 | 2001 | 9 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase 10 | 1 | 2001 | 2 | 0.010 |
Why?
|
| Fura-2 | 1 | 2001 | 12 | 0.010 |
Why?
|
| Leukotrienes | 1 | 2001 | 4 | 0.010 |
Why?
|
| Muscarinic Agonists | 1 | 2001 | 10 | 0.010 |
Why?
|
| Microvilli | 1 | 2001 | 9 | 0.010 |
Why?
|
| Triiodothyronine | 1 | 2001 | 32 | 0.010 |
Why?
|
| Behavioral Symptoms | 1 | 2001 | 6 | 0.010 |
Why?
|
| Muscarinic Antagonists | 1 | 2001 | 12 | 0.010 |
Why?
|
| Organ Culture Techniques | 1 | 2001 | 103 | 0.010 |
Why?
|
| Propionates | 1 | 2001 | 26 | 0.010 |
Why?
|
| COS Cells | 1 | 2000 | 69 | 0.010 |
Why?
|
| Ketones | 1 | 2001 | 17 | 0.010 |
Why?
|
| Cholic Acid | 1 | 2000 | 2 | 0.010 |
Why?
|
| Thiouracil | 1 | 2000 | 3 | 0.010 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2000 | 33 | 0.010 |
Why?
|
| Macromolecular Substances | 1 | 2001 | 96 | 0.010 |
Why?
|
| Acetylcholine | 1 | 2001 | 73 | 0.010 |
Why?
|
| Tritium | 2 | 1992 | 51 | 0.010 |
Why?
|
| Cell-Free System | 1 | 2000 | 15 | 0.010 |
Why?
|
| Conserved Sequence | 1 | 2000 | 119 | 0.010 |
Why?
|
| Quinolines | 1 | 2001 | 64 | 0.010 |
Why?
|
| Multigene Family | 1 | 2000 | 106 | 0.010 |
Why?
|
| Superoxides | 1 | 2000 | 53 | 0.010 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2000 | 73 | 0.010 |
Why?
|
| Ions | 1 | 2000 | 61 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2000 | 269 | 0.010 |
Why?
|
| 3,3'-Diaminobenzidine | 1 | 2000 | 3 | 0.010 |
Why?
|
| Ferric Compounds | 1 | 2000 | 51 | 0.010 |
Why?
|
| Corpus Striatum | 1 | 2001 | 104 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 2000 | 325 | 0.010 |
Why?
|
| Dithiothreitol | 1 | 1999 | 18 | 0.010 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2001 | 132 | 0.010 |
Why?
|
| Epithelial Cells | 1 | 2003 | 384 | 0.010 |
Why?
|
| Hela Cells | 1 | 2000 | 366 | 0.010 |
Why?
|
| Movement | 1 | 1980 | 97 | 0.010 |
Why?
|
| Catalysis | 1 | 2000 | 179 | 0.010 |
Why?
|
| Rats, Inbred BN | 1 | 1999 | 21 | 0.010 |
Why?
|
| Succinimides | 1 | 1999 | 10 | 0.010 |
Why?
|
| Phosphoproteins | 1 | 2000 | 163 | 0.010 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2000 | 206 | 0.010 |
Why?
|
| Plasmids | 1 | 2000 | 246 | 0.010 |
Why?
|
| Chromatography, Gel | 1 | 1999 | 50 | 0.010 |
Why?
|
| Ca(2+) Mg(2+)-ATPase | 1 | 1998 | 6 | 0.010 |
Why?
|
| Anion Transport Proteins | 1 | 1998 | 2 | 0.010 |
Why?
|
| Hydrolysis | 1 | 1999 | 99 | 0.010 |
Why?
|
| Polyethylene Glycols | 1 | 1999 | 84 | 0.010 |
Why?
|
| bcl-Associated Death Protein | 1 | 1998 | 9 | 0.010 |
Why?
|
| Caspase 2 | 1 | 1998 | 7 | 0.010 |
Why?
|
| bcl-2 Homologous Antagonist-Killer Protein | 1 | 1998 | 4 | 0.010 |
Why?
|
| Enzyme Precursors | 1 | 1998 | 14 | 0.010 |
Why?
|
| PC12 Cells | 1 | 1998 | 93 | 0.010 |
Why?
|
| bcl-X Protein | 1 | 1998 | 27 | 0.010 |
Why?
|
| Crystallins | 1 | 1997 | 2 | 0.010 |
Why?
|
| bcl-2-Associated X Protein | 1 | 1998 | 77 | 0.010 |
Why?
|
| Meningeal Arteries | 1 | 1997 | 1 | 0.010 |
Why?
|
| Mollusca | 1 | 1997 | 14 | 0.010 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 1996 | 17 | 0.010 |
Why?
|
| RNA-Directed DNA Polymerase | 1 | 1995 | 18 | 0.010 |
Why?
|
| Pons | 1 | 1995 | 9 | 0.010 |
Why?
|
| Cytochrome c Group | 1 | 1995 | 16 | 0.010 |
Why?
|
| Phospholipase C delta | 1 | 1995 | 1 | 0.010 |
Why?
|
| Osmolar Concentration | 1 | 1995 | 58 | 0.010 |
Why?
|
| Glutamate-Ammonia Ligase | 1 | 1993 | 10 | 0.010 |
Why?
|
| Receptors, Transferrin | 1 | 1993 | 15 | 0.010 |
Why?
|
| Phosphatidylinositol Diacylglycerol-Lyase | 1 | 1993 | 5 | 0.010 |
Why?
|
| Capillary Permeability | 1 | 1993 | 30 | 0.010 |
Why?
|
| Video Recording | 1 | 1993 | 32 | 0.010 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1993 | 52 | 0.010 |
Why?
|
| Pharyngeal Diseases | 1 | 1993 | 6 | 0.010 |
Why?
|
| CHO Cells | 1 | 1993 | 124 | 0.010 |
Why?
|
| Rats, Inbred SHR | 1 | 1993 | 32 | 0.010 |
Why?
|
| Eye Diseases | 1 | 1993 | 24 | 0.010 |
Why?
|
| Platelet Membrane Glycoproteins | 1 | 1992 | 4 | 0.010 |
Why?
|
| Thrombospondins | 1 | 1992 | 3 | 0.010 |
Why?
|
| Guanosine Diphosphate Mannose | 1 | 1992 | 2 | 0.010 |
Why?
|
| Splenectomy | 1 | 1992 | 8 | 0.010 |
Why?
|
| Uridine Diphosphate N-Acetylglucosamine | 1 | 1992 | 5 | 0.010 |
Why?
|
| Sulfur Radioisotopes | 1 | 1992 | 7 | 0.010 |
Why?
|
| Cell Fusion | 1 | 1992 | 19 | 0.010 |
Why?
|
| Clone Cells | 1 | 1992 | 47 | 0.010 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 1992 | 18 | 0.010 |
Why?
|
| Glycosylphosphatidylinositols | 1 | 1992 | 21 | 0.010 |
Why?
|
| Genetic Complementation Test | 1 | 1992 | 59 | 0.010 |
Why?
|
| Mannose | 1 | 1992 | 25 | 0.010 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 1992 | 56 | 0.010 |
Why?
|
| Breast Neoplasms | 1 | 2003 | 1502 | 0.010 |
Why?
|
| Lymphoma | 1 | 1992 | 38 | 0.010 |
Why?
|
| Cell Adhesion Molecules | 1 | 1992 | 75 | 0.010 |
Why?
|
| Antigens, CD | 1 | 1992 | 121 | 0.010 |
Why?
|
| Cell Adhesion | 1 | 1992 | 212 | 0.010 |
Why?
|
| Animals, Suckling | 1 | 1990 | 10 | 0.010 |
Why?
|
| Horseradish Peroxidase | 1 | 1990 | 25 | 0.010 |
Why?
|
| Nickel | 1 | 1990 | 20 | 0.010 |
Why?
|
| Fixatives | 1 | 1989 | 7 | 0.010 |
Why?
|
| Protease Inhibitors | 1 | 1989 | 49 | 0.010 |
Why?
|
| Mice, Inbred C3H | 1 | 1988 | 84 | 0.010 |
Why?
|
| Spectrin | 1 | 1988 | 5 | 0.000 |
Why?
|
| Motor Neurons | 1 | 1988 | 83 | 0.000 |
Why?
|
| Ankyrins | 1 | 1988 | 6 | 0.000 |
Why?
|
| Anion Exchange Protein 1, Erythrocyte | 1 | 1988 | 6 | 0.000 |
Why?
|
| Cyclosporins | 1 | 1987 | 2 | 0.000 |
Why?
|
| Egtazic Acid | 1 | 1987 | 13 | 0.000 |
Why?
|
| Vinculin | 1 | 1987 | 6 | 0.000 |
Why?
|
| N-Formylmethionine Leucyl-Phenylalanine | 1 | 1984 | 3 | 0.000 |
Why?
|
| Colchicine | 1 | 1984 | 15 | 0.000 |
Why?
|
| Fetal Blood | 1 | 1984 | 50 | 0.000 |
Why?
|
| Antigen-Antibody Reactions | 1 | 1983 | 20 | 0.000 |
Why?
|
| Placenta | 1 | 1984 | 97 | 0.000 |
Why?
|
| Guinea Pigs | 1 | 1983 | 145 | 0.000 |
Why?
|
| Hybridomas | 1 | 1983 | 29 | 0.000 |
Why?
|
| Immunization | 1 | 1983 | 92 | 0.000 |
Why?
|
| Starfish | 1 | 1982 | 2 | 0.000 |
Why?
|
| Fishes | 1 | 1982 | 53 | 0.000 |
Why?
|